| 28870487 | CV869173 | single nucleotide variant | NM_080911.3(UNG):c.*2C>A | Hyper-IgM syndrome type 5 [RCV001113585] | uncertain significance | 12 | 109109971 | 109109971 | Human | 1 | name |
| 11604077 | CV315876 | single nucleotide variant | NM_080911.3(UNG):c.-51A>T | Hyper-IgM syndrome type 5 [RCV000305902] | uncertain significance | 12 | 109097629 | 109097629 | Human | 1 | name |
| 11663046 | CV330261 | single nucleotide variant | NM_080911.3(UNG):c.-73C>T | Hyper-IgM syndrome type 5 [RCV000391677] | uncertain significance | 12 | 109097607 | 109097607 | Human | 1 | name |
| 28873637 | CV869166 | single nucleotide variant | NM_080911.3(UNG):c.-51A>G | Hyper-IgM syndrome type 5 [RCV001115106] | uncertain significance | 12 | 109097629 | 109097629 | Human | 1 | name |
| 28873640 | CV869167 | single nucleotide variant | NM_080911.3(UNG):c.-50G>A | Hyper-IgM syndrome type 5 [RCV001115107] | uncertain significance | 12 | 109097630 | 109097630 | Human | 1 | name |
| 11661733 | CV315888 | duplication | NM_080911.3(UNG):c.*788dup | Hyperimmunoglobulin M syndrome [RCV001844117] | likely benign | 12 | 109110749 | 109110750 | Human | 1 | name |
| 11648031 | CV323026 | single nucleotide variant | NM_080911.3(UNG):c.*159G>A | Hyper-IgM syndrome type 5 [RCV000279628] | uncertain significance | 12 | 109110128 | 109110128 | Human | 1 | name |
| 11612359 | CV323034 | single nucleotide variant | NM_080911.3(UNG):c.*522A>G | Hyper-IgM syndrome type 5 [RCV000407340] | uncertain significance | 12 | 109110491 | 109110491 | Human | 1 | name |
| 11609036 | CV323036 | single nucleotide variant | NM_080911.3(UNG):c.*545A>G | Hyper-IgM syndrome type 5 [RCV000362912] | uncertain significance | 12 | 109110514 | 109110514 | Human | 1 | name |
| 11599338 | CV323043 | single nucleotide variant | NM_080911.3(UNG):c.*708T>C | Hyper-IgM syndrome type 5 [RCV000264692] | likely benign|uncertain significance | 12 | 109110677 | 109110677 | Human | 1 | name |
| 11609869 | CV323044 | single nucleotide variant | NM_080911.3(UNG):c.*880A>T | Hyper-IgM syndrome type 5 [RCV000373697] | uncertain significance | 12 | 109110849 | 109110849 | Human | 1 | name |
| 11656887 | CV329083 | single nucleotide variant | NM_080911.3(UNG):c.*281C>T | Hyper-IgM syndrome type 5 [RCV000336984] | uncertain significance | 12 | 109110250 | 109110250 | Human | 1 | name |
| 11618179 | CV329092 | single nucleotide variant | NM_080911.3(UNG):c.*463C>T | Hyper-IgM syndrome type 5 [RCV000311250] | likely benign|uncertain significance | 12 | 109110432 | 109110432 | Human | 1 | name |
| 11654161 | CV329094 | single nucleotide variant | NM_080911.3(UNG):c.*537G>A | Hyper-IgM syndrome type 5 [RCV000315261] | uncertain significance | 12 | 109110506 | 109110506 | Human | 1 | name |
| 11617936 | CV329096 | single nucleotide variant | NM_080911.3(UNG):c.*655A>C | Hyper-IgM syndrome type 5 [RCV000309188] | uncertain significance | 12 | 109110624 | 109110624 | Human | 1 | name |
| 11622952 | CV329107 | single nucleotide variant | NM_080911.3(UNG):c.*699T>C | Hyper-IgM syndrome type 5 [RCV000366239] | uncertain significance | 12 | 109110668 | 109110668 | Human | 1 | name |
| 11620928 | CV330267 | single nucleotide variant | NM_080911.3(UNG):c.*109A>G | Hyper-IgM syndrome type 5 [RCV000342482] | uncertain significance | 12 | 109110078 | 109110078 | Human | 1 | name |
| 11623347 | CV330272 | single nucleotide variant | NM_080911.3(UNG):c.*111A>T | Hyper-IgM syndrome type 5 [RCV000371536] | uncertain significance | 12 | 109110080 | 109110080 | Human | 1 | name |
| 11664011 | CV330276 | single nucleotide variant | NM_080911.3(UNG):c.*313C>G | Hyper-IgM syndrome type 5 [RCV000401327] | uncertain significance | 12 | 109110282 | 109110282 | Human | 1 | name |
| 11621564 | CV330282 | single nucleotide variant | NM_080911.3(UNG):c.*500C>G | Hyperimmunoglobulin M syndrome [RCV001844116] | uncertain significance | 12 | 109110469 | 109110469 | Human | 1 | name |
| 11646398 | CV330283 | single nucleotide variant | NM_080911.3(UNG):c.*611C>T | Hyper-IgM syndrome type 5 [RCV000270439] | uncertain significance | 12 | 109110580 | 109110580 | Human | 1 | name |
| 11655022 | CV330291 | single nucleotide variant | NM_080911.3(UNG):c.*719G>A | Hyper-IgM syndrome type 5 [RCV000322389] | uncertain significance | 12 | 109110688 | 109110688 | Human | 1 | name |
| 28870490 | CV869174 | single nucleotide variant | NM_080911.3(UNG):c.*129C>T | Hyper-IgM syndrome type 5 [RCV001113586] | uncertain significance | 12 | 109110098 | 109110098 | Human | 1 | name |
| 28870494 | CV869175 | single nucleotide variant | NM_080911.3(UNG):c.*376C>G | Hyper-IgM syndrome type 5 [RCV001113587] | uncertain significance | 12 | 109110345 | 109110345 | Human | 1 | name |
| 28910881 | CV869176 | single nucleotide variant | NM_080911.3(UNG):c.*445C>T | Hyper-IgM syndrome type 5 [RCV001109581] | uncertain significance | 12 | 109110414 | 109110414 | Human | 1 | name |
| 28910882 | CV869177 | single nucleotide variant | NM_080911.3(UNG):c.*573G>C | Hyper-IgM syndrome type 5 [RCV001109582] | uncertain significance | 12 | 109110542 | 109110542 | Human | 1 | name |
| 28867502 | CV869178 | single nucleotide variant | NM_080911.3(UNG):c.*705T>C | Hyper-IgM syndrome type 5 [RCV001111857] | uncertain significance | 12 | 109110674 | 109110674 | Human | 1 | name |
| 28867505 | CV869179 | single nucleotide variant | NM_080911.3(UNG):c.*858T>G | Hyper-IgM syndrome type 5 [RCV001111858] | uncertain significance | 12 | 109110827 | 109110827 | Human | 1 | name |
| 126775076 | CV1030632 | single nucleotide variant | NM_080911.3(UNG):c.802-8T>A | Hyper-IgM syndrome type 5 [RCV001347963] | uncertain significance | 12 | 109109821 | 109109821 | Human | 1 | name |
| 127278842 | CV1079072 | single nucleotide variant | NM_080911.3(UNG):c.133-7C>T | Hyper-IgM syndrome type 5 [RCV001408758] | likely benign | 12 | 109098425 | 109098425 | Human | 1 | name |
| 127314686 | CV1122264 | single nucleotide variant | NM_080911.3(UNG):c.622+9G>T | Hyper-IgM syndrome type 5 [RCV001457774] | likely benign | 12 | 109102936 | 109102936 | Human | 1 | name |
| 151724507 | CV1439987 | single nucleotide variant | NM_080911.3(UNG):c.623-2A>G | Hyper-IgM syndrome type 5 [RCV002040511] | likely pathogenic | 12 | 109103431 | 109103431 | Human | 1 | name |
| 151728660 | CV1444468 | single nucleotide variant | NM_080911.3(UNG):c.801+5G>A | Hyper-IgM syndrome type 5 [RCV001945816] | uncertain significance | 12 | 109103616 | 109103616 | Human | 1 | name |
| 156299741 | CV2075820 | single nucleotide variant | NM_080911.3(UNG):c.133-8A>C | Hyper-IgM syndrome type 5 [RCV002857110] | likely benign | 12 | 109098424 | 109098424 | Human | 1 | name |
| 155977038 | CV2151252 | single nucleotide variant | NM_080911.3(UNG):c.622+6C>G | Hyper-IgM syndrome type 5 [RCV003033699] | uncertain significance | 12 | 109102933 | 109102933 | Human | 1 | name |
| 404996576 | CV2892401 | single nucleotide variant | NM_080911.3(UNG):c.132+1G>A | Hyper-IgM syndrome type 5 [RCV003513396] | likely pathogenic | 12 | 109097812 | 109097812 | Human | 1 | name |
| 402473016 | CV2945762 | single nucleotide variant | NM_080911.3(UNG):c.133-2A>G | Hyper-IgM syndrome type 5 [RCV003624665] | likely pathogenic | 12 | 109098430 | 109098430 | Human | 1 | name |
| 402481401 | CV3019995 | single nucleotide variant | NM_080911.3(UNG):c.802-9C>T | Hyper-IgM syndrome type 5 [RCV003626099] | likely benign | 12 | 109109820 | 109109820 | Human | 1 | name |
| 405184327 | CV3124108 | single nucleotide variant | NM_080911.3(UNG):c.435+9A>G | Hyper-IgM syndrome type 5 [RCV003820304] | likely benign | 12 | 109099293 | 109099293 | Human | 1 | name |
| 405233713 | CV3145024 | single nucleotide variant | NM_080911.3(UNG):c.623-9T>C | Hyper-IgM syndrome type 5 [RCV003853281] | likely benign | 12 | 109103424 | 109103424 | Human | 1 | name |
| 11600322 | CV315878 | single nucleotide variant | NM_080911.3(UNG):c.623-9T>A | Hyper-IgM syndrome type 5 [RCV001044991] | uncertain significance | 12 | 109103424 | 109103424 | Human | 1 | name |
| 11619566 | CV329059 | single nucleotide variant | NM_080911.3(UNG):c.533+6G>A | Hyper-IgM syndrome type 5 [RCV000625198]|UNG-related disorder [RCV003977892]|not provided [RCV003992268] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 12 | 109102005 | 109102005 | Human | 1 | name , trait , alternate_id |
| 11620623 | CV329111 | single nucleotide variant | NM_080911.3(UNG):c.*1018A>G | Hyper-IgM syndrome type 5 [RCV000338933] | uncertain significance | 12 | 109110987 | 109110987 | Human | 1 | name |
| 11614978 | CV330299 | single nucleotide variant | NM_080911.3(UNG):c.*1013T>A | Hyper-IgM syndrome type 5 [RCV000281414] | benign|likely benign | 12 | 109110982 | 109110982 | Human | 1 | name |
| 408383748 | CV3525826 | single nucleotide variant | NM_080911.3(UNG):c.339+6T>C | not specified [RCV004766736] | uncertain significance | 12 | 109098644 | 109098644 | Human | | name |
| 14707216 | CV652201 | single nucleotide variant | NM_080911.3(UNG):c.802-6T>C | Hyper-IgM syndrome type 5 [RCV000792257] | uncertain significance | 12 | 109109823 | 109109823 | Human | 1 | name |
| 15115971 | CV775961 | single nucleotide variant | NM_080911.3(UNG):c.436-5C>T | not provided [RCV000939583] | likely benign | 12 | 109101897 | 109101897 | Human | | name |
| 38495723 | CV960020 | single nucleotide variant | NM_080911.3(UNG):c.340-3C>T | Hyper-IgM syndrome type 5 [RCV001225908] | uncertain significance | 12 | 109099186 | 109099186 | Human | 1 | name |
| 127267652 | CV1079073 | single nucleotide variant | NM_080911.3(UNG):c.339+15G>A | Hyper-IgM syndrome type 5 [RCV001404168] | likely benign | 12 | 109098653 | 109098653 | Human | 1 | name |
| 150469951 | CV1219159 | single nucleotide variant | NM_080911.3(UNG):c.623-67T>C | not provided [RCV001614911] | benign | 12 | 109103366 | 109103366 | Human | | name |
| 150497448 | CV1219408 | single nucleotide variant | NM_080911.3(UNG):c.802-47T>A | not provided [RCV001620077] | benign | 12 | 109109782 | 109109782 | Human | | name |
| 150436594 | CV1220571 | single nucleotide variant | NM_080911.3(UNG):c.802-48A>T | not provided [RCV001609555] | benign | 12 | 109109781 | 109109781 | Human | | name |
| 150457204 | CV1237042 | duplication | NM_080911.3(UNG):c.622+42dup | not provided [RCV001648721] | benign | 12 | 109102947 | 109102948 | Human | | name |
| 150501857 | CV1241056 | duplication | NM_080911.3(UNG):c.534-25dup | not provided [RCV001656952]|not specified [RCV003487612] | benign | 12 | 109102808 | 109102809 | Human | | name |
| 152117464 | CV1524178 | duplication | NM_080911.3(UNG):c.801+27dup | Hyper-IgM syndrome type 5 [RCV002135276] | benign | 12 | 109103630 | 109103631 | Human | 1 | name |
| 152042355 | CV1537958 | single nucleotide variant | NM_080911.3(UNG):c.802-20T>G | Hyper-IgM syndrome type 5 [RCV002165855] | likely benign | 12 | 109109809 | 109109809 | Human | 1 | name |
| 152063046 | CV1542196 | single nucleotide variant | NM_080911.3(UNG):c.622+16C>T | Hyper-IgM syndrome type 5 [RCV002208931] | likely benign | 12 | 109102943 | 109102943 | Human | 1 | name |
| 152079607 | CV1550006 | single nucleotide variant | NM_080911.3(UNG):c.533+18G>A | Hyper-IgM syndrome type 5 [RCV002192857] | likely benign | 12 | 109102017 | 109102017 | Human | 1 | name |
| 152133083 | CV1557413 | single nucleotide variant | NM_080911.3(UNG):c.436-19G>A | Hyper-IgM syndrome type 5 [RCV002137188] | likely benign | 12 | 109101883 | 109101883 | Human | 1 | name |
| 152135282 | CV1560333 | single nucleotide variant | NM_080911.3(UNG):c.533+15C>G | Hyper-IgM syndrome type 5 [RCV002137454] | likely benign | 12 | 109102014 | 109102014 | Human | 1 | name |
| 152152207 | CV1572492 | single nucleotide variant | NM_080911.3(UNG):c.801+14T>C | Hyper-IgM syndrome type 5 [RCV002139689] | likely benign | 12 | 109103625 | 109103625 | Human | 1 | name |
| 152132160 | CV1585035 | single nucleotide variant | NM_080911.3(UNG):c.339+11A>C | Hyper-IgM syndrome type 5 [RCV002083009]|not provided [RCV004704712] | likely benign | 12 | 109098649 | 109098649 | Human | 1 | name |
| 152136352 | CV1587836 | single nucleotide variant | NM_080911.3(UNG):c.340-20C>T | Hyper-IgM syndrome type 5 [RCV002083556] | likely benign | 12 | 109099169 | 109099169 | Human | 1 | name |
| 152118637 | CV1593515 | single nucleotide variant | NM_080911.3(UNG):c.623-13C>G | Hyper-IgM syndrome type 5 [RCV002097841] | likely benign | 12 | 109103420 | 109103420 | Human | 1 | name |
| 152120069 | CV1612227 | single nucleotide variant | NM_080911.3(UNG):c.435+15T>C | Hyper-IgM syndrome type 5 [RCV002135597] | likely benign | 12 | 109099299 | 109099299 | Human | 1 | name |
| 152168955 | CV1614011 | single nucleotide variant | NM_080911.3(UNG):c.533+17G>T | Hyper-IgM syndrome type 5 [RCV002161287] | likely benign | 12 | 109102016 | 109102016 | Human | 1 | name |
| 152165175 | CV1649015 | single nucleotide variant | NM_080911.3(UNG):c.534-14T>C | Hyper-IgM syndrome type 5 [RCV002204187] | likely benign | 12 | 109102825 | 109102825 | Human | 1 | name |
| 152147415 | CV1656137 | single nucleotide variant | NM_080911.3(UNG):c.132+16G>T | Hyper-IgM syndrome type 5 [RCV002220265] | likely benign | 12 | 109097827 | 109097827 | Human | 1 | name |
| 152090786 | CV1662023 | single nucleotide variant | NM_080911.3(UNG):c.339+17A>C | Hyper-IgM syndrome type 5 [RCV002132017] | benign | 12 | 109098655 | 109098655 | Human | 1 | name |
| 152054633 | CV1665470 | single nucleotide variant | NM_080911.3(UNG):c.132+14T>G | Hyper-IgM syndrome type 5 [RCV002089557] | likely benign | 12 | 109097825 | 109097825 | Human | 1 | name |
| 155268772 | CV1705599 | deletion | NM_080911.3(UNG):c.802-48del | not provided [RCV002286206] | likely benign | 12 | 109109764 | 109109764 | Human | | name |
| 156269881 | CV1870645 | single nucleotide variant | NM_080911.3(UNG):c.435+11C>T | Hyper-IgM syndrome type 5 [RCV003060675] | likely benign | 12 | 109099295 | 109099295 | Human | 1 | name |
| 156400193 | CV1897531 | single nucleotide variant | NM_080911.3(UNG):c.623-11C>G | Hyper-IgM syndrome type 5 [RCV002584791] | likely benign | 12 | 109103422 | 109103422 | Human | 1 | name |
| 156080054 | CV1959852 | single nucleotide variant | NM_080911.3(UNG):c.801+18T>C | Hyper-IgM syndrome type 5 [RCV002569880] | likely benign | 12 | 109103629 | 109103629 | Human | 1 | name |
| 156315086 | CV2017932 | single nucleotide variant | NM_080911.3(UNG):c.132+19C>T | Hyper-IgM syndrome type 5 [RCV002671855] | likely benign | 12 | 109097830 | 109097830 | Human | 1 | name |
| 155962905 | CV2037827 | single nucleotide variant | NM_080911.3(UNG):c.339+18C>T | Hyper-IgM syndrome type 5 [RCV002776357] | likely benign | 12 | 109098656 | 109098656 | Human | 1 | name |
| 156000502 | CV2045531 | single nucleotide variant | NM_080911.3(UNG):c.622+11G>A | Hyper-IgM syndrome type 5 [RCV002756178] | likely benign | 12 | 109102938 | 109102938 | Human | 1 | name |
| 402473178 | CV2960124 | single nucleotide variant | NM_080911.3(UNG):c.622+19G>C | Hyper-IgM syndrome type 5 [RCV003624701] | likely benign | 12 | 109102946 | 109102946 | Human | 1 | name |
| 402480499 | CV3017004 | single nucleotide variant | NM_080911.3(UNG):c.339+13A>G | Hyper-IgM syndrome type 5 [RCV003625923] | likely benign | 12 | 109098651 | 109098651 | Human | 1 | name |
| 402474748 | CV3074712 | single nucleotide variant | NM_080911.3(UNG):c.622+20A>T | Hyper-IgM syndrome type 5 [RCV003625054] | likely benign | 12 | 109102947 | 109102947 | Human | 1 | name |
| 405172732 | CV3122863 | single nucleotide variant | NM_080911.3(UNG):c.133-19C>T | Hyper-IgM syndrome type 5 [RCV003819261] | likely benign | 12 | 109098413 | 109098413 | Human | 1 | name |
| 405161599 | CV3125063 | single nucleotide variant | NM_080911.3(UNG):c.623-15C>A | Hyper-IgM syndrome type 5 [RCV003818334] | likely benign | 12 | 109103418 | 109103418 | Human | 1 | name |
| 405052554 | CV3138306 | single nucleotide variant | NM_080911.3(UNG):c.801+16T>C | Hyper-IgM syndrome type 5 [RCV003832150] | likely benign | 12 | 109103627 | 109103627 | Human | 1 | name |
| 402466417 | CV3173571 | single nucleotide variant | NM_080911.3(UNG):c.802-12G>C | Hyper-IgM syndrome type 5 [RCV003873045] | likely benign | 12 | 109109817 | 109109817 | Human | 1 | name |
| 404992484 | CV3183875 | single nucleotide variant | NM_080911.3(UNG):c.802-15C>A | Hyper-IgM syndrome type 5 [RCV003881648] | likely benign | 12 | 109109814 | 109109814 | Human | 1 | name |
| 11623274 | CV329058 | single nucleotide variant | NM_080911.3(UNG):c.435+15T>A | Hyper-IgM syndrome type 5 [RCV000370574] | conflicting interpretations of pathogenicity|uncertain significance | 12 | 109099299 | 109099299 | Human | 1 | name |
| 11654338 | CV329110 | microsatellite | NM_080911.3(UNG):c.*866AT[5] | Hyperimmunoglobulin M syndrome [RCV001844119] | uncertain significance | 12 | 109110835 | 109110840 | Human | | name |
| 11613425 | CV330295 | microsatellite | NM_080911.3(UNG):c.*866AT[9] | Hyperimmunoglobulin M syndrome [RCV001844118] | likely benign | 12 | 109110834 | 109110835 | Human | | name |
| 597875330 | CV3743814 | single nucleotide variant | NM_080911.3(UNG):c.802-18A>G | Hyper-IgM syndrome type 5 [RCV005069220] | likely benign | 12 | 109109811 | 109109811 | Human | 1 | name |
| 597953056 | CV3843892 | single nucleotide variant | NM_080911.3(UNG):c.623-15C>T | Hyper-IgM syndrome type 5 [RCV005190754] | likely benign | 12 | 109103418 | 109103418 | Human | 1 | name |
| 597888461 | CV3859505 | duplication | NM_080911.3(UNG):c.622+18dup | Hyper-IgM syndrome type 5 [RCV005200161] | likely benign | 12 | 109102944 | 109102945 | Human | 1 | name |
| 28868074 | CV872185 | single nucleotide variant | NM_080911.3(UNG):c.622+10C>T | Hyper-IgM syndrome type 5 [RCV001112233] | benign|likely benign | 12 | 109102937 | 109102937 | Human | 1 | name |
| 150459111 | CV1236046 | single nucleotide variant | NM_080911.3(UNG):c.132+193A>G | not provided [RCV001649017] | benign | 12 | 109098004 | 109098004 | Human | | name |
| 150494993 | CV1241495 | single nucleotide variant | NM_080911.3(UNG):c.133-221C>T | not provided [RCV001655502] | benign | 12 | 109098211 | 109098211 | Human | | name |
| 150469928 | CV1247903 | single nucleotide variant | NM_080911.3(UNG):c.132+241T>A | not provided [RCV001670939] | benign | 12 | 109098052 | 109098052 | Human | | name |
| 150461064 | CV1253195 | single nucleotide variant | NM_080911.3(UNG):c.339+116A>C | not provided [RCV001669524] | benign | 12 | 109098754 | 109098754 | Human | | name |
| 405275445 | CV3204780 | single nucleotide variant | NM_080911.3(UNG):c.133-110C>T | UNG-related disorder [RCV003952159] | likely benign | 12 | 109098322 | 109098322 | Human | | name , trait , alternate_id |
| 8603070 | CV45554 | deletion | NM_080911.3(UNG):c.*70_*71del | not specified [RCV002281722] | uncertain significance | 12 | 109110037 | 109110038 | Human | | name |
| 11658980 | CV323016 | single nucleotide variant | NM_080911.3(UNG):c.6C>A (p.Ile2=) | Hyper-IgM syndrome type 5 [RCV000353520] | uncertain significance | 12 | 109097685 | 109097685 | Human | 1 | name |
| 402470678 | CV3033657 | deletion | NM_080911.3(UNG):c.623-10_623-9del | Hyper-IgM syndrome type 5 [RCV003624040] | likely benign | 12 | 109103423 | 109103424 | Human | 1 | name |
| 127318879 | CV1122261 | single nucleotide variant | NM_080911.3(UNG):c.36C>T (p.Ser12=) | Hyper-IgM syndrome type 5 [RCV001466389] | likely benign | 12 | 109097715 | 109097715 | Human | 1 | name |
| 127320163 | CV1156892 | deletion | NM_080911.3(UNG):c.801+24_801+27del | Hyper-IgM syndrome type 5 [RCV001522495] | benign | 12 | 109103631 | 109103634 | Human | 1 | name |
| 150504960 | CV1211502 | duplication | NM_080911.3(UNG):c.802-53_802-48dup | not provided [RCV001595667] | benign | 12 | 109109763 | 109109764 | Human | | name |
| 151709314 | CV1409191 | single nucleotide variant | NM_080911.3(UNG):c.90G>T (p.Gly30=) | Hyper-IgM syndrome type 5 [RCV001907650]|not specified [RCV005238020] | likely benign|uncertain significance | 12 | 109097769 | 109097769 | Human | 1 | name |
| 156295368 | CV1995276 | single nucleotide variant | NM_080911.3(UNG):c.90G>A (p.Gly30=) | Hyper-IgM syndrome type 5 [RCV002670930] | likely benign | 12 | 109097769 | 109097769 | Human | 1 | name |
| 156120616 | CV2013762 | microsatellite | NM_080911.3(UNG):c.801+19_801+22del | Hyper-IgM syndrome type 5 [RCV002740182] | likely benign | 12 | 109103623 | 109103626 | Human | | name |
| 401917475 | CV2829876 | duplication | NM_080911.3(UNG):c.802-51_802-48dup | not provided [RCV003443920] | likely benign | 12 | 109109763 | 109109764 | Human | | name |
| 404986075 | CV2854415 | single nucleotide variant | NM_080911.3(UNG):c.60C>T (p.His20=) | Hyper-IgM syndrome type 5 [RCV003512298] | likely benign | 12 | 109097739 | 109097739 | Human | 1 | name |
| 405092761 | CV3118840 | duplication | NM_080911.3(UNG):c.133-13_133-10dup | Hyper-IgM syndrome type 5 [RCV003811291] | likely benign | 12 | 109098418 | 109098419 | Human | 1 | name |
| 11624877 | CV329045 | single nucleotide variant | NM_080911.3(UNG):c.81C>A (p.Ala27=) | Hyper-IgM syndrome type 5 [RCV000391668] | conflicting interpretations of pathogenicity|uncertain significance | 12 | 109097760 | 109097760 | Human | 1 | name |
| 597868314 | CV3742909 | deletion | NM_080911.3(UNG):c.801+19_801+21del | Hyper-IgM syndrome type 5 [RCV005068332] | likely benign | 12 | 109103628 | 109103630 | Human | 1 | name |
| 28873643 | CV869168 | single nucleotide variant | NM_080911.3(UNG):c.36C>A (p.Ser12=) | Hyper-IgM syndrome type 5 [RCV001115108] | conflicting interpretations of pathogenicity|uncertain significance | 12 | 109097715 | 109097715 | Human | 1 | name |
| 126910159 | CV1047645 | single nucleotide variant | NM_080911.3(UNG):c.14A>G (p.Lys5Arg) | Hyper-IgM syndrome type 5 [RCV001368796] | uncertain significance | 12 | 109097693 | 109097693 | Human | 1 | name |
| 127270168 | CV1100810 | single nucleotide variant | NM_080911.3(UNG):c.126T>C (p.Asp42=) | Hyper-IgM syndrome type 5 [RCV001430525] | likely benign | 12 | 109097805 | 109097805 | Human | 1 | name |
| 127305940 | CV1122262 | single nucleotide variant | NM_080911.3(UNG):c.186C>T (p.Pro62=) | Hyper-IgM syndrome type 5 [RCV001455361] | likely benign | 12 | 109098485 | 109098485 | Human | 1 | name |
| 152128317 | CV1581345 | single nucleotide variant | NM_080911.3(UNG):c.120C>T (p.Ser40=) | Hyper-IgM syndrome type 5 [RCV002099136] | likely benign | 12 | 109097799 | 109097799 | Human | 1 | name |
| 152091126 | CV1602810 | single nucleotide variant | NM_080911.3(UNG):c.273C>G (p.Pro91=) | Hyper-IgM syndrome type 5 [RCV002194312] | likely benign | 12 | 109098572 | 109098572 | Human | 1 | name |
| 152080371 | CV1620716 | single nucleotide variant | NM_080911.3(UNG):c.267C>T (p.Asn89=) | Hyper-IgM syndrome type 5 [RCV002112666] | likely benign | 12 | 109098566 | 109098566 | Human | 1 | name |
| 152073755 | CV1657653 | single nucleotide variant | NM_080911.3(UNG):c.153C>G (p.Ala51=) | Hyper-IgM syndrome type 5 [RCV002210319] | likely benign | 12 | 109098452 | 109098452 | Human | 1 | name |
| 153303904 | CV1686514 | single nucleotide variant | NM_080911.3(UNG):c.16A>G (p.Thr6Ala) | not provided [RCV002261948] | uncertain significance | 12 | 109097695 | 109097695 | Human | | name |
| 156004513 | CV1906267 | single nucleotide variant | NM_080911.3(UNG):c.105G>A (p.Gly35=) | Hyper-IgM syndrome type 5 [RCV003098961] | likely benign | 12 | 109097784 | 109097784 | Human | 1 | name |
| 156439082 | CV1943950 | single nucleotide variant | NM_080911.3(UNG):c.141A>G (p.Pro47=) | Hyper-IgM syndrome type 5 [RCV003109035] | likely benign | 12 | 109098440 | 109098440 | Human | 1 | name |
| 156108254 | CV2140017 | deletion | NM_080911.3(UNG):c.39del (p.Ser14fs) | Hyper-IgM syndrome type 5 [RCV003002484] | pathogenic | 12 | 109097714 | 109097714 | Human | 1 | name |
| 156365530 | CV2192180 | single nucleotide variant | NM_080911.3(UNG):c.273C>T (p.Pro91=) | Hyper-IgM syndrome type 5 [RCV003065926] | likely benign | 12 | 109098572 | 109098572 | Human | 1 | name |
| 404989143 | CV2932063 | single nucleotide variant | NM_080911.3(UNG):c.129G>A (p.Ala43=) | Hyper-IgM syndrome type 5 [RCV003512623] | likely benign | 12 | 109097808 | 109097808 | Human | 1 | name |
| 402480846 | CV3022913 | single nucleotide variant | NM_080911.3(UNG):c.138C>A (p.Ile46=) | Hyper-IgM syndrome type 5 [RCV003626032] | likely benign | 12 | 109098437 | 109098437 | Human | 1 | name |
| 402471672 | CV3057356 | single nucleotide variant | NM_080911.3(UNG):c.237C>T (p.Ala79=) | Hyper-IgM syndrome type 5 [RCV003624303] | likely benign | 12 | 109098536 | 109098536 | Human | 1 | name |
| 402471677 | CV3057361 | single nucleotide variant | NM_080911.3(UNG):c.168G>A (p.Glu56=) | Hyper-IgM syndrome type 5 [RCV003624304] | likely benign | 12 | 109098467 | 109098467 | Human | 1 | name |
| 405211013 | CV3117749 | single nucleotide variant | NM_080911.3(UNG):c.135C>T (p.Ala45=) | Hyper-IgM syndrome type 5 [RCV003823348] | likely benign | 12 | 109098434 | 109098434 | Human | 1 | name |
| 405131495 | CV3163720 | single nucleotide variant | NM_080911.3(UNG):c.189C>G (p.Ser63=) | Hyper-IgM syndrome type 5 [RCV003854708] | likely benign | 12 | 109098488 | 109098488 | Human | 1 | name |
| 11622179 | CV329053 | single nucleotide variant | NM_080911.3(UNG):c.204C>G (p.Ala68=) | Hyper-IgM syndrome type 5 [RCV000357072] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 12 | 109098503 | 109098503 | Human | 1 | name |
| 11614193 | CV330262 | single nucleotide variant | NM_080911.3(UNG):c.204C>T (p.Ala68=) | Hyper-IgM syndrome type 5 [RCV000274915] | uncertain significance | 12 | 109098503 | 109098503 | Human | 1 | name |
| 597842550 | CV3831041 | single nucleotide variant | NM_080911.3(UNG):c.102T>C (p.Ala34=) | Hyper-IgM syndrome type 5 [RCV005172422] | likely benign | 12 | 109097781 | 109097781 | Human | 1 | name |
| 597963063 | CV3841363 | single nucleotide variant | NM_080911.3(UNG):c.159T>C (p.Ala53=) | Hyper-IgM syndrome type 5 [RCV005193466] | likely benign | 12 | 109098458 | 109098458 | Human | 1 | name |
| 597950930 | CV3847003 | single nucleotide variant | NM_080911.3(UNG):c.150G>A (p.Lys50=) | Hyper-IgM syndrome type 5 [RCV005190174] | likely benign | 12 | 109098449 | 109098449 | Human | 1 | name |
| 8603071 | CV45555 | single nucleotide variant | NM_080911.3(UNG):c.246G>C (p.Leu82=) | Hyper-IgM syndrome type 5 [RCV000030577]|not provided [RCV001705610] | benign|likely benign|conflicting interpretations of pathogenicity | 12 | 109098545 | 109098545 | Human | 1 | name |
| 13473997 | CV462161 | single nucleotide variant | NM_080911.3(UNG):c.291C>T (p.Ser97=) | Hyper-IgM syndrome type 5 [RCV000525628]|not provided [RCV004707325] | benign | 12 | 109098590 | 109098590 | Human | 1 | name |
| 15170048 | CV713314 | single nucleotide variant | NM_080911.3(UNG):c.183G>A (p.Pro61=) | Hyper-IgM syndrome type 5 [RCV000971936]|UNG-related disorder [RCV003972930]|not provided [RCV001702575] | likely benign|conflicting interpretations of pathogenicity | 12 | 109098482 | 109098482 | Human | 1 | name , trait , alternate_id |
| 15176862 | CV768873 | single nucleotide variant | NM_080911.3(UNG):c.285A>G (p.Gly95=) | Hyper-IgM syndrome type 5 [RCV000929016] | likely benign | 12 | 109098584 | 109098584 | Human | 1 | name |
| 127237936 | CV1079074 | single nucleotide variant | NM_080911.3(UNG):c.513G>A (p.Arg171=) | Hyper-IgM syndrome type 5 [RCV001397236] | likely benign | 12 | 109101979 | 109101979 | Human | 1 | name |
| 127237349 | CV1079075 | single nucleotide variant | NM_080911.3(UNG):c.522G>A (p.Pro174=) | Hyper-IgM syndrome type 5 [RCV001414891] | likely benign | 12 | 109101988 | 109101988 | Human | 1 | name |
| 127273694 | CV1079076 | single nucleotide variant | NM_080911.3(UNG):c.681G>A (p.Lys227=) | Hyper-IgM syndrome type 5 [RCV001406141] | likely benign | 12 | 109103491 | 109103491 | Human | 1 | name |
| 127239885 | CV1079077 | single nucleotide variant | NM_080911.3(UNG):c.738G>T (p.Ser246=) | Hyper-IgM syndrome type 5 [RCV001415454] | likely benign | 12 | 109103548 | 109103548 | Human | 1 | name |
| 127283356 | CV1079078 | single nucleotide variant | NM_080911.3(UNG):c.906G>A (p.Lys302=) | Hyper-IgM syndrome type 5 [RCV001411733]|UNG-related disorder [RCV003938702] | likely benign | 12 | 109109933 | 109109933 | Human | 1 | name , trait , alternate_id |
| 127242706 | CV1100811 | single nucleotide variant | NM_080911.3(UNG):c.633T>C (p.Leu211=) | Hyper-IgM syndrome type 5 [RCV001423799] | likely benign | 12 | 109103443 | 109103443 | Human | 1 | name |
| 127269765 | CV1100812 | single nucleotide variant | NM_080911.3(UNG):c.744C>G (p.Gly248=) | Hyper-IgM syndrome type 5 [RCV001430361] | likely benign | 12 | 109103554 | 109103554 | Human | 1 | name |
| 127316456 | CV1122263 | single nucleotide variant | NM_080911.3(UNG):c.471T>C (p.His157=) | Hyper-IgM syndrome type 5 [RCV001465546] | likely benign | 12 | 109101937 | 109101937 | Human | 1 | name |
| 151720951 | CV1396789 | single nucleotide variant | NM_080911.3(UNG):c.399A>G (p.Gln133=) | Hyper-IgM syndrome type 5 [RCV001891090] | uncertain significance | 12 | 109099248 | 109099248 | Human | 1 | name |
| 151744179 | CV1427987 | single nucleotide variant | NM_080911.3(UNG):c.76C>T (p.Pro26Ser) | Hyper-IgM syndrome type 5 [RCV001926775] | uncertain significance | 12 | 109097755 | 109097755 | Human | 1 | name |
| 151738520 | CV1437427 | single nucleotide variant | NM_080911.3(UNG):c.62C>T (p.Ala21Val) | Hyper-IgM syndrome type 5 [RCV001870777] | uncertain significance | 12 | 109097741 | 109097741 | Human | 1 | name |
| 151854047 | CV1453447 | single nucleotide variant | NM_080911.3(UNG):c.34T>A (p.Ser12Thr) | Hyper-IgM syndrome type 5 [RCV001883111] | uncertain significance | 12 | 109097713 | 109097713 | Human | 1 | name |
| 152162456 | CV1535050 | single nucleotide variant | NM_080911.3(UNG):c.771T>C (p.Tyr257=) | Hyper-IgM syndrome type 5 [RCV002141153] | likely benign | 12 | 109103581 | 109103581 | Human | 1 | name |
| 152161990 | CV1543846 | single nucleotide variant | NM_080911.3(UNG):c.639C>T (p.Asn213=) | Hyper-IgM syndrome type 5 [RCV002159801] | likely benign | 12 | 109103449 | 109103449 | Human | 1 | name |
| 152052535 | CV1607258 | single nucleotide variant | NM_080911.3(UNG):c.696G>A (p.Glu232=) | Hyper-IgM syndrome type 5 [RCV002109157] | likely benign | 12 | 109103506 | 109103506 | Human | 1 | name |
| 152115089 | CV1628159 | single nucleotide variant | NM_080911.3(UNG):c.408C>T (p.Thr136=) | Hyper-IgM syndrome type 5 [RCV002197289] | likely benign | 12 | 109099257 | 109099257 | Human | 1 | name |
| 152040357 | CV1640051 | single nucleotide variant | NM_080911.3(UNG):c.486T>C (p.Ala162=) | Hyper-IgM syndrome type 5 [RCV002087869] | likely benign | 12 | 109101952 | 109101952 | Human | 1 | name |
| 156379211 | CV1876842 | single nucleotide variant | NM_080911.3(UNG):c.489C>T (p.His163=) | Hyper-IgM syndrome type 5 [RCV003067022] | likely benign | 12 | 109101955 | 109101955 | Human | 1 | name |
| 155987972 | CV2026739 | single nucleotide variant | NM_080911.3(UNG):c.77C>A (p.Pro26Gln) | Hyper-IgM syndrome type 5 [RCV002755624] | uncertain significance | 12 | 109097756 | 109097756 | Human | 1 | name |
| 156100636 | CV2107351 | duplication | NM_080911.3(UNG):c.250dup (p.Arg84fs) | Hyper-IgM syndrome type 5 [RCV002927038] | pathogenic | 12 | 109098548 | 109098549 | Human | 1 | name |
| 155993053 | CV2125952 | deletion | NM_080911.3(UNG):c.162del (p.Gln55fs) | Hyper-IgM syndrome type 5 [RCV002974821] | pathogenic | 12 | 109098459 | 109098459 | Human | 1 | name |
| 156342273 | CV2127678 | single nucleotide variant | NM_080911.3(UNG):c.495C>T (p.Leu165=) | Hyper-IgM syndrome type 5 [RCV002938961] | likely benign | 12 | 109101961 | 109101961 | Human | 1 | name |
| 155946592 | CV2130274 | single nucleotide variant | NM_080911.3(UNG):c.895C>T (p.Leu299=) | Hyper-IgM syndrome type 5 [RCV002971616] | likely benign | 12 | 109109922 | 109109922 | Human | 1 | name |
| 156052838 | CV2165354 | single nucleotide variant | NM_080911.3(UNG):c.324A>G (p.Lys108=) | Hyper-IgM syndrome type 5 [RCV003019456] | likely benign | 12 | 109098623 | 109098623 | Human | 1 | name |
| 156192723 | CV2171327 | single nucleotide variant | NM_080911.3(UNG):c.924T>A (p.Ile308=) | Hyper-IgM syndrome type 5 [RCV003024186]|not specified [RCV005239605] | likely benign | 12 | 109109951 | 109109951 | Human | 1 | name |
| 402475185 | CV2971855 | single nucleotide variant | NM_080911.3(UNG):c.654T>C (p.Val218=) | Hyper-IgM syndrome type 5 [RCV003625139] | likely benign | 12 | 109103464 | 109103464 | Human | 1 | name |
| 402471230 | CV3052195 | single nucleotide variant | NM_080911.3(UNG):c.312G>C (p.Gly104=) | Hyper-IgM syndrome type 5 [RCV003624191] | likely benign | 12 | 109098611 | 109098611 | Human | 1 | name |
| 405191476 | CV3118129 | single nucleotide variant | NM_080911.3(UNG):c.303C>T (p.His101=) | Hyper-IgM syndrome type 5 [RCV003821039] | likely benign | 12 | 109098602 | 109098602 | Human | 1 | name |
| 405184038 | CV3124131 | single nucleotide variant | NM_080911.3(UNG):c.519T>C (p.Val173=) | Hyper-IgM syndrome type 5 [RCV003820328] | likely benign | 12 | 109101985 | 109101985 | Human | 1 | name |
| 405058845 | CV3129369 | single nucleotide variant | NM_080911.3(UNG):c.783G>A (p.Lys261=) | Hyper-IgM syndrome type 5 [RCV003832638] | likely benign | 12 | 109103593 | 109103593 | Human | 1 | name |
| 11599876 | CV323023 | single nucleotide variant | NM_080911.3(UNG):c.528G>A (p.Pro176=) | Hyper-IgM syndrome type 5 [RCV000540196]|not provided [RCV003391079]|not specified [RCV005238878] | benign|uncertain significance | 12 | 109101994 | 109101994 | Human | 1 | name |
| 11605540 | CV323024 | single nucleotide variant | NM_080911.3(UNG):c.660C>T (p.Ala220=) | Hyper-IgM syndrome type 5 [RCV000320800] | uncertain significance | 12 | 109103470 | 109103470 | Human | 1 | name |
| 11623802 | CV330263 | single nucleotide variant | NM_080911.3(UNG):c.759C>G (p.Leu253=) | Hyper-IgM syndrome type 5 [RCV000555072]|not provided [RCV004708220] | benign|likely benign | 12 | 109103569 | 109103569 | Human | 1 | name |
| 597968638 | CV3761180 | single nucleotide variant | NM_080911.3(UNG):c.35C>T (p.Ser12Phe) | Hyper-IgM syndrome type 5 [RCV005083567] | uncertain significance | 12 | 109097714 | 109097714 | Human | 1 | name |
| 597937596 | CV3774720 | single nucleotide variant | NM_080911.3(UNG):c.888C>G (p.Thr296=) | Hyper-IgM syndrome type 5 [RCV005117753] | likely benign | 12 | 109109915 | 109109915 | Human | 1 | name |
| 597942268 | CV3779872 | single nucleotide variant | NM_080911.3(UNG):c.858G>A (p.Gly286=) | Hyper-IgM syndrome type 5 [RCV005118881] | likely benign | 12 | 109109885 | 109109885 | Human | 1 | name |
| 597971978 | CV3798963 | single nucleotide variant | NM_080911.3(UNG):c.402C>T (p.Val134=) | Hyper-IgM syndrome type 5 [RCV005142375] | likely benign | 12 | 109099251 | 109099251 | Human | 1 | name |
| 597914676 | CV3851167 | single nucleotide variant | NM_080911.3(UNG):c.888C>T (p.Thr296=) | Hyper-IgM syndrome type 5 [RCV005204135] | likely benign | 12 | 109109915 | 109109915 | Human | 1 | name |
| 597903282 | CV3851532 | single nucleotide variant | NM_080911.3(UNG):c.558G>A (p.Leu186=) | Hyper-IgM syndrome type 5 [RCV005202309] | likely benign | 12 | 109102863 | 109102863 | Human | 1 | name |
| 8603072 | CV45556 | single nucleotide variant | NM_080911.3(UNG):c.732G>A (p.Gln244=) | Hyper-IgM syndrome type 5 [RCV000030578] | likely benign | 12 | 109103542 | 109103542 | Human | 1 | name |
| 13821258 | CV565032 | single nucleotide variant | NM_080911.3(UNG):c.651G>A (p.Thr217=) | Hyper-IgM syndrome type 5 [RCV000695630]|UNG-related disorder [RCV003980314] | likely benign|uncertain significance | 12 | 109103461 | 109103461 | Human | 1 | name , trait , alternate_id |
| 14722367 | CV640589 | single nucleotide variant | NM_080911.3(UNG):c.61G>A (p.Ala21Thr) | Hyper-IgM syndrome type 5 [RCV000797528]|not specified [RCV004027600] | uncertain significance | 12 | 109097740 | 109097740 | Human | 1 | name |
| 15120925 | CV753070 | single nucleotide variant | NM_080911.3(UNG):c.738G>A (p.Ser246=) | Hyper-IgM syndrome type 5 [RCV000918396] | likely benign | 12 | 109103548 | 109103548 | Human | 1 | name |
| 15128913 | CV768874 | single nucleotide variant | NM_080911.3(UNG):c.825G>A (p.Thr275=) | Hyper-IgM syndrome type 5 [RCV001112236] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 12 | 109109852 | 109109852 | Human | 1 | name |
| 15121239 | CV784260 | single nucleotide variant | NM_080911.3(UNG):c.819A>G (p.Leu273=) | Hyper-IgM syndrome type 5 [RCV001506327] | likely benign | 12 | 109109846 | 109109846 | Human | 1 | name |
| 28910792 | CV869169 | single nucleotide variant | NM_080911.3(UNG):c.65C>T (p.Pro22Leu) | Hyper-IgM syndrome type 5 [RCV001109467] | uncertain significance | 12 | 109097744 | 109097744 | Human | 1 | name |
| 28910793 | CV869170 | single nucleotide variant | NM_080911.3(UNG):c.86A>C (p.Gln29Pro) | Hyper-IgM syndrome type 5 [RCV001109468] | uncertain significance | 12 | 109097765 | 109097765 | Human | 1 | name |
| 38481952 | CV926451 | single nucleotide variant | NM_080911.3(UNG):c.32T>C (p.Phe11Ser) | Hyper-IgM syndrome type 5 [RCV001218242]|not specified [RCV004034062] | uncertain significance | 12 | 109097711 | 109097711 | Human | 1 | name |
| 126744384 | CV1010086 | single nucleotide variant | NM_080911.3(UNG):c.173C>T (p.Pro58Leu) | Hyper-IgM syndrome type 5 [RCV001314932]|not specified [RCV004034333] | uncertain significance | 12 | 109098472 | 109098472 | Human | 1 | name |
| 126921664 | CV1047646 | single nucleotide variant | NM_080911.3(UNG):c.155C>G (p.Pro52Arg) | Hyper-IgM syndrome type 5 [RCV001363752] | uncertain significance | 12 | 109098454 | 109098454 | Human | 1 | name |
| 126920524 | CV1047647 | single nucleotide variant | NM_080911.3(UNG):c.191C>G (p.Ser64Trp) | Hyper-IgM syndrome type 5 [RCV001373856] | uncertain significance | 12 | 109098490 | 109098490 | Human | 1 | name |
| 126921269 | CV1047648 | single nucleotide variant | NM_080911.3(UNG):c.268G>C (p.Val90Leu) | Hyper-IgM syndrome type 5 [RCV001363379]|not specified [RCV004036880] | uncertain significance | 12 | 109098567 | 109098567 | Human | 1 | name |
| 126908867 | CV1047649 | single nucleotide variant | NM_080911.3(UNG):c.271C>G (p.Pro91Ala) | Hyper-IgM syndrome type 5 [RCV001368132] | uncertain significance | 12 | 109098570 | 109098570 | Human | 1 | name |
| 150471563 | CV1259140 | insertion | NM_080911.3(UNG):c.802-48_802-47insAAT | not provided [RCV001684385] | benign | 12 | 109109781 | 109109782 | Human | | name |
| 150551980 | CV1300797 | duplication | NM_080911.3(UNG):c.799dup (p.Arg267fs) | not provided [RCV001754657] | uncertain significance | 12 | 109103608 | 109103609 | Human | | name |
| 151793555 | CV1420463 | single nucleotide variant | NM_080911.3(UNG):c.110C>A (p.Pro37His) | Hyper-IgM syndrome type 5 [RCV002027440] | uncertain significance | 12 | 109097789 | 109097789 | Human | 1 | name |
| 151834709 | CV1452816 | single nucleotide variant | NM_080911.3(UNG):c.188C>T (p.Ser63Phe) | Hyper-IgM syndrome type 5 [RCV001880655] | uncertain significance | 12 | 109098487 | 109098487 | Human | 1 | name |
| 151769842 | CV1460328 | single nucleotide variant | NM_080911.3(UNG):c.200G>A (p.Ser67Asn) | Hyper-IgM syndrome type 5 [RCV001863970] | uncertain significance | 12 | 109098499 | 109098499 | Human | 1 | name |
| 152999324 | CV1679764 | duplication | NM_080911.3(UNG):c.649dup (p.Thr217fs) | Hyper-IgM syndrome type 5 [RCV002251153] | pathogenic | 12 | 109103458 | 109103459 | Human | 1 | name |
| 156378760 | CV1876745 | single nucleotide variant | NM_080911.3(UNG):c.288G>C (p.Glu96Asp) | Hyper-IgM syndrome type 5 [RCV003066976] | uncertain significance | 12 | 109098587 | 109098587 | Human | 1 | name |
| 156203220 | CV2021319 | single nucleotide variant | NM_080911.3(UNG):c.134C>T (p.Ala45Val) | Hyper-IgM syndrome type 5 [RCV002711475] | uncertain significance | 12 | 109098433 | 109098433 | Human | 1 | name |
| 156138495 | CV2177715 | single nucleotide variant | NM_080911.3(UNG):c.263G>C (p.Arg88Pro) | Hyper-IgM syndrome type 5 [RCV003039952] | uncertain significance | 12 | 109098562 | 109098562 | Human | 1 | name |
| 8563029 | CV27329 | deletion | NM_080911.3(UNG):c.392del (p.Pro131fs) | Hyper-IgM syndrome type 5 [RCV000013084] | pathogenic | 12 | 109099237 | 109099237 | Human | 1 | name |
| 11651608 | CV323018 | single nucleotide variant | NM_080911.3(UNG):c.100G>A (p.Ala34Thr) | Hyper-IgM syndrome type 5 [RCV000299867] | uncertain significance | 12 | 109097779 | 109097779 | Human | 1 | name |
| 11620074 | CV329054 | single nucleotide variant | NM_080911.3(UNG):c.231C>G (p.Asn77Lys) | Hyper-IgM syndrome type 5 [RCV000332287] | uncertain significance | 12 | 109098530 | 109098530 | Human | 1 | name |
| 405810159 | CV3345141 | single nucleotide variant | NM_080911.3(UNG):c.266A>G (p.Asn89Ser) | not specified [RCV004482101] | uncertain significance | 12 | 109098565 | 109098565 | Human | | name |
| 597670043 | CV3707108 | single nucleotide variant | NM_080911.3(UNG):c.294G>A (p.Trp98Ter) | Hyper-IgM syndrome type 5 [RCV005004784] | likely pathogenic | 12 | 109098593 | 109098593 | Human | 1 | name |
| 597906009 | CV3785145 | deletion | NM_080911.3(UNG):c.682del (p.Glu228fs) | Hyper-IgM syndrome type 5 [RCV005127988] | pathogenic | 12 | 109103491 | 109103491 | Human | 1 | name |
| 597941504 | CV3785809 | deletion | NM_080911.3(UNG):c.348del (p.Phe117fs) | Hyper-IgM syndrome type 5 [RCV005133702] | pathogenic | 12 | 109099197 | 109099197 | Human | 1 | name |
| 598127559 | CV3882739 | single nucleotide variant | NM_080911.3(UNG):c.114G>C (p.Glu38Asp) | Hyper-IgM syndrome type 5 [RCV005234270] | uncertain significance | 12 | 109097793 | 109097793 | Human | 1 | name |
| 13436302 | CV434025 | single nucleotide variant | NM_080911.3(UNG):c.262C>T (p.Arg88Cys) | Hyper-IgM syndrome type 5 [RCV000687269]|not provided [RCV000506946] | conflicting interpretations of pathogenicity|uncertain significance | 12 | 109098561 | 109098561 | Human | 1 | name |
| 13482118 | CV461582 | single nucleotide variant | NM_080911.3(UNG):c.146A>G (p.Lys49Arg) | Hyper-IgM syndrome type 5 [RCV000551728] | likely benign|uncertain significance | 12 | 109098445 | 109098445 | Human | 1 | name |
| 13607327 | CV526630 | single nucleotide variant | NM_080911.3(UNG):c.265A>G (p.Asn89Asp) | Hyper-IgM syndrome type 5 [RCV000639383] | uncertain significance | 12 | 109098564 | 109098564 | Human | 1 | name |
| 13706069 | CV537209 | deletion | NM_080911.3(UNG):c.309del (p.Ser103fs) | not provided [RCV000658665] | likely pathogenic | 12 | 109098608 | 109098608 | Human | | name |
| 14730095 | CV640590 | single nucleotide variant | NM_080911.3(UNG):c.260C>T (p.Ala87Val) | Hyper-IgM syndrome type 5 [RCV000800808] | uncertain significance | 12 | 109098559 | 109098559 | Human | 1 | name |
| 15165642 | CV724868 | single nucleotide variant | NM_080911.3(UNG):c.194C>T (p.Pro65Leu) | Hyper-IgM syndrome type 5 [RCV001109469] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 12 | 109098493 | 109098493 | Human | 1 | name |
| 38482155 | CV926452 | single nucleotide variant | NM_080911.3(UNG):c.124G>C (p.Asp42His) | Hyper-IgM syndrome type 5 [RCV001218333] | uncertain significance | 12 | 109097803 | 109097803 | Human | 1 | name |
| 126908721 | CV969946 | single nucleotide variant | NM_080911.3(UNG):c.289A>T (p.Ser97Cys) | Hereditary breast ovarian cancer syndrome [RCV001374544] | uncertain significance | 12 | 109098588 | 109098588 | Human | 1 | name |
| 126750439 | CV994876 | single nucleotide variant | NM_080911.3(UNG):c.232A>G (p.Lys78Glu) | Hyper-IgM syndrome type 5 [RCV001297320] | uncertain significance | 12 | 109098531 | 109098531 | Human | 1 | name |
| 126766033 | CV1010087 | duplication | NM_080911.3(UNG):c.891dup (p.Glu298Ter) | Hyper-IgM syndrome type 5 [RCV001320279] | uncertain significance | 12 | 109109917 | 109109918 | Human | 1 | name |
| 126741103 | CV1017555 | single nucleotide variant | NM_080911.3(UNG):c.490G>A (p.Gly164Arg) | Hyper-IgM syndrome type 5 [RCV001329608] | uncertain significance | 12 | 109101956 | 109101956 | Human | 1 | name |
| 126730522 | CV1020971 | single nucleotide variant | NM_080911.3(UNG):c.710C>G (p.Ala237Gly) | Hyper-IgM syndrome type 5 [RCV001333460] | uncertain significance | 12 | 109103520 | 109103520 | Human | 1 | name |
| 126911124 | CV1047650 | single nucleotide variant | NM_080911.3(UNG):c.524C>T (p.Pro175Leu) | Hyper-IgM syndrome type 5 [RCV001369081] | uncertain significance | 12 | 109101990 | 109101990 | Human | 1 | name |
| 126914449 | CV1047651 | single nucleotide variant | NM_080911.3(UNG):c.548A>G (p.Tyr183Cys) | Hyper-IgM syndrome type 5 [RCV001370477] | uncertain significance | 12 | 109102853 | 109102853 | Human | 1 | name |
| 126912670 | CV1047652 | single nucleotide variant | NM_080911.3(UNG):c.721T>C (p.Trp241Arg) | Hyper-IgM syndrome type 5 [RCV001369820] | uncertain significance | 12 | 109103531 | 109103531 | Human | 1 | name |
| 126918368 | CV1047653 | single nucleotide variant | NM_080911.3(UNG):c.796G>C (p.Asp266His) | Hyper-IgM syndrome type 5 [RCV001372619] | uncertain significance | 12 | 109103606 | 109103606 | Human | 1 | name |
| 127263603 | CV1062570 | single nucleotide variant | NM_080911.3(UNG):c.730C>T (p.Gln244Ter) | Hyper-IgM syndrome type 5 [RCV001387995] | pathogenic | 12 | 109103540 | 109103540 | Human | 1 | name |
| 150477620 | CV1279484 | insertion | NM_080911.3(UNG):c.802-48_802-47insAAAT | not provided [RCV001714157] | benign | 12 | 109109781 | 109109782 | Human | | name |
| 151878791 | CV1370164 | single nucleotide variant | NM_080911.3(UNG):c.934G>A (p.Glu312Lys) | Hyper-IgM syndrome type 5 [RCV001961376] | uncertain significance | 12 | 109109961 | 109109961 | Human | 1 | name |
| 151852399 | CV1378854 | single nucleotide variant | NM_080911.3(UNG):c.514C>G (p.Pro172Ala) | Hyper-IgM syndrome type 5 [RCV001882920]|not specified [RCV004040602] | uncertain significance | 12 | 109101980 | 109101980 | Human | 1 | name |
| 151864884 | CV1380784 | single nucleotide variant | NM_080911.3(UNG):c.523C>G (p.Pro175Ala) | Hyper-IgM syndrome type 5 [RCV002018215] | uncertain significance | 12 | 109101989 | 109101989 | Human | 1 | name |
| 151814273 | CV1382324 | single nucleotide variant | NM_080911.3(UNG):c.586C>T (p.Pro196Ser) | Hyper-IgM syndrome type 5 [RCV001992130] | uncertain significance | 12 | 109102891 | 109102891 | Human | 1 | name |
| 151808608 | CV1383984 | single nucleotide variant | NM_080911.3(UNG):c.371A>G (p.His124Arg) | Hyper-IgM syndrome type 5 [RCV001878039] | uncertain significance | 12 | 109099220 | 109099220 | Human | 1 | name |
| 151765463 | CV1387514 | single nucleotide variant | NM_080911.3(UNG):c.489C>G (p.His163Gln) | Hyper-IgM syndrome type 5 [RCV001987731] | uncertain significance | 12 | 109101955 | 109101955 | Human | 1 | name |
| 151838950 | CV1415142 | single nucleotide variant | NM_080911.3(UNG):c.851A>G (p.Tyr284Cys) | Hyper-IgM syndrome type 5 [RCV001921299] | uncertain significance | 12 | 109109878 | 109109878 | Human | 1 | name |
| 151729659 | CV1416606 | single nucleotide variant | NM_080911.3(UNG):c.399A>C (p.Gln133His) | Hyper-IgM syndrome type 5 [RCV002004636]|not specified [RCV004043926] | uncertain significance | 12 | 109099248 | 109099248 | Human | 1 | name |
| 151793621 | CV1420472 | single nucleotide variant | NM_080911.3(UNG):c.686G>A (p.Arg229Gln) | Hyper-IgM syndrome type 5 [RCV002027446] | uncertain significance | 12 | 109103496 | 109103496 | Human | 1 | name |
| 151839366 | CV1492893 | single nucleotide variant | NM_080911.3(UNG):c.583C>A (p.His195Asn) | Hyper-IgM syndrome type 5 [RCV001881156] | uncertain significance | 12 | 109102888 | 109102888 | Human | 1 | name |
| 151773895 | CV1504903 | single nucleotide variant | NM_080911.3(UNG):c.541A>G (p.Asn181Asp) | Hyper-IgM syndrome type 5 [RCV002009107] | uncertain significance | 12 | 109102846 | 109102846 | Human | 1 | name |
| 156386897 | CV1875084 | single nucleotide variant | NM_080911.3(UNG):c.674C>T (p.Ser225Phe) | Hyper-IgM syndrome type 5 [RCV003050936] | uncertain significance | 12 | 109103484 | 109103484 | Human | 1 | name |
| 156183392 | CV1884795 | single nucleotide variant | NM_080911.3(UNG):c.580G>A (p.Val194Ile) | Hyper-IgM syndrome type 5 [RCV003083635] | uncertain significance | 12 | 109102885 | 109102885 | Human | 1 | name |
| 155952607 | CV1896334 | single nucleotide variant | NM_080911.3(UNG):c.487C>T (p.His163Tyr) | Hyper-IgM syndrome type 5 [RCV003095415] | uncertain significance | 12 | 109101953 | 109101953 | Human | 1 | name |
| 156137991 | CV1902239 | single nucleotide variant | NM_080911.3(UNG):c.527C>T (p.Pro176Leu) | Hyper-IgM syndrome type 5 [RCV003082091] | uncertain significance | 12 | 109101993 | 109101993 | Human | 1 | name |
| 155984812 | CV1907472 | single nucleotide variant | NM_080911.3(UNG):c.579T>G (p.Phe193Leu) | Hyper-IgM syndrome type 5 [RCV003097552] | benign | 12 | 109102884 | 109102884 | Human | 1 | name |
| 156415454 | CV1958508 | single nucleotide variant | NM_080911.3(UNG):c.631C>T (p.Leu211Phe) | Hyper-IgM syndrome type 5 [RCV002589179] | uncertain significance | 12 | 109103441 | 109103441 | Human | 1 | name |
| 156072703 | CV2015541 | single nucleotide variant | NM_080911.3(UNG):c.640G>A (p.Ala214Thr) | Hyper-IgM syndrome type 5 [RCV002705733] | uncertain significance | 12 | 109103450 | 109103450 | Human | 1 | name |
| 156182741 | CV2020549 | single nucleotide variant | NM_080911.3(UNG):c.634C>G (p.Leu212Val) | Hyper-IgM syndrome type 5 [RCV002710833] | uncertain significance | 12 | 109103444 | 109103444 | Human | 1 | name |
| 156347470 | CV2051984 | single nucleotide variant | NM_080911.3(UNG):c.489C>A (p.His163Gln) | Hyper-IgM syndrome type 5 [RCV002811541] | uncertain significance | 12 | 109101955 | 109101955 | Human | 1 | name |
| 156130541 | CV2114825 | single nucleotide variant | NM_080911.3(UNG):c.521C>T (p.Pro174Leu) | Hyper-IgM syndrome type 5 [RCV002914535]|not specified [RCV004066281] | uncertain significance | 12 | 109101987 | 109101987 | Human | 1 | name |
| 155942609 | CV2115047 | single nucleotide variant | NM_080911.3(UNG):c.388C>A (p.Pro130Thr) | Hyper-IgM syndrome type 5 [RCV002904575] | uncertain significance | 12 | 109099237 | 109099237 | Human | 1 | name |
| 156008787 | CV2127561 | single nucleotide variant | NM_080911.3(UNG):c.824C>G (p.Thr275Arg) | Hyper-IgM syndrome type 5 [RCV002948149] | uncertain significance | 12 | 109109851 | 109109851 | Human | 1 | name |
| 155976972 | CV2151239 | single nucleotide variant | NM_080911.3(UNG):c.737C>T (p.Ser246Leu) | Hyper-IgM syndrome type 5 [RCV003033696] | uncertain significance | 12 | 109103547 | 109103547 | Human | 1 | name |
| 155963349 | CV2282730 | single nucleotide variant | NM_080911.3(UNG):c.389C>T (p.Pro130Leu) | not specified [RCV004141592] | uncertain significance | 12 | 109099238 | 109099238 | Human | | name |
| 156179399 | CV2298375 | single nucleotide variant | NM_080911.3(UNG):c.442G>T (p.Val148Phe) | not specified [RCV004160266] | uncertain significance | 12 | 109101908 | 109101908 | Human | | name |
| 401724871 | CV2672329 | single nucleotide variant | NM_080911.3(UNG):c.339G>T (p.Lys113Asn) | not provided [RCV003239230] | uncertain significance | 12 | 109098638 | 109098638 | Human | | name |
| 8598963 | CV27331 | single nucleotide variant | NM_080911.3(UNG):c.752T>C (p.Phe251Ser) | Hyper-IgM syndrome type 5 [RCV000013086] | pathogenic | 12 | 109103562 | 109103562 | Human | 1 | name |
| 404991684 | CV2856437 | single nucleotide variant | NM_080911.3(UNG):c.925G>A (p.Asp309Asn) | Hyper-IgM syndrome type 5 [RCV003512882] | uncertain significance | 12 | 109109952 | 109109952 | Human | 1 | name |
| 404994516 | CV2869865 | single nucleotide variant | NM_080911.3(UNG):c.437T>G (p.Val146Gly) | Hyper-IgM syndrome type 5 [RCV003513225] | uncertain significance | 12 | 109101903 | 109101903 | Human | 1 | name |
| 11610609 | CV315877 | single nucleotide variant | NM_080911.3(UNG):c.544A>G (p.Ile182Val) | Hyper-IgM syndrome type 5 [RCV000791786] | uncertain significance | 12 | 109102849 | 109102849 | Human | 1 | name |
| 11615395 | CV329061 | single nucleotide variant | NM_080911.3(UNG):c.769T>C (p.Tyr257His) | Hyper-IgM syndrome type 5 [RCV000285151]|not provided [RCV000520946]|not specified [RCV004021531] | uncertain significance | 12 | 109103579 | 109103579 | Human | 1 | name |
| 407454782 | CV3489385 | single nucleotide variant | NM_080911.3(UNG):c.338A>G (p.Lys113Arg) | not specified [RCV004685230] | uncertain significance | 12 | 109098637 | 109098637 | Human | | name |
| 407454785 | CV3489386 | single nucleotide variant | NM_080911.3(UNG):c.488A>G (p.His163Arg) | not specified [RCV004685231] | uncertain significance | 12 | 109101954 | 109101954 | Human | | name |
| 408388692 | CV3522699 | single nucleotide variant | NM_080911.3(UNG):c.313G>T (p.Glu105Ter) | Hyper-IgM syndrome type 5 [RCV005104946]|not provided [RCV004769080] | pathogenic|uncertain significance | 12 | 109098612 | 109098612 | Human | 1 | name |
| 597670052 | CV3707109 | single nucleotide variant | NM_080911.3(UNG):c.454G>T (p.Gly152Ter) | Hyper-IgM syndrome type 5 [RCV005004785] | likely pathogenic | 12 | 109101920 | 109101920 | Human | 1 | name |
| 597914457 | CV3778885 | single nucleotide variant | NM_080911.3(UNG):c.570A>G (p.Ile190Met) | Hyper-IgM syndrome type 5 [RCV005129230] | uncertain significance | 12 | 109102875 | 109102875 | Human | 1 | name |
| 597941544 | CV3785817 | single nucleotide variant | NM_080911.3(UNG):c.343A>T (p.Met115Leu) | Hyper-IgM syndrome type 5 [RCV005133710] | uncertain significance | 12 | 109099192 | 109099192 | Human | 1 | name |
| 597900883 | CV3796625 | single nucleotide variant | NM_080911.3(UNG):c.514C>A (p.Pro172Thr) | Hyper-IgM syndrome type 5 [RCV005152707] | uncertain significance | 12 | 109101980 | 109101980 | Human | 1 | name |
| 598191409 | CV3925715 | single nucleotide variant | NM_080911.3(UNG):c.880T>A (p.Ser294Thr) | not specified [RCV005288354] | uncertain significance | 12 | 109109907 | 109109907 | Human | | name |
| 13490009 | CV461584 | single nucleotide variant | NM_080911.3(UNG):c.843G>T (p.Leu281Phe) | Hyper-IgM syndrome type 5 [RCV000533213]|not provided [RCV003884610] | likely benign | 12 | 109109870 | 109109870 | Human | 1 | name |
| 13607331 | CV526638 | single nucleotide variant | NM_080911.3(UNG):c.911G>A (p.Gly304Asp) | Hyper-IgM syndrome type 5 [RCV000639384] | uncertain significance | 12 | 109109938 | 109109938 | Human | 1 | name |
| 13814511 | CV571181 | single nucleotide variant | NM_080911.3(UNG):c.392C>T (p.Pro131Leu) | Hyper-IgM syndrome type 5 [RCV000705084] | likely benign|uncertain significance | 12 | 109099241 | 109099241 | Human | 1 | name |
| 13807872 | CV571184 | single nucleotide variant | NM_080911.3(UNG):c.685C>T (p.Arg229Ter) | Hyper-IgM syndrome type 5 [RCV000701366] | pathogenic | 12 | 109103495 | 109103495 | Human | 1 | name |
| 14703677 | CV640591 | single nucleotide variant | NM_080911.3(UNG):c.366A>C (p.Arg122Ser) | Hyper-IgM syndrome type 5 [RCV000807482]|not specified [RCV004028615] | uncertain significance | 12 | 109099215 | 109099215 | Human | 1 | name |
| 14736687 | CV640592 | single nucleotide variant | NM_080911.3(UNG):c.593A>G (p.His198Arg) | Hyper-IgM syndrome type 5 [RCV000803713]|not specified [RCV001192880] | uncertain significance | 12 | 109102898 | 109102898 | Human | 1 | name |
| 14735442 | CV640593 | single nucleotide variant | NM_080911.3(UNG):c.805C>T (p.Arg269Trp) | Hyper-IgM syndrome type 5 [RCV000803154] | uncertain significance | 12 | 109109832 | 109109832 | Human | 1 | name |
| 21074319 | CV796681 | duplication | NM_080911.3(UNG):c.501dup (p.Ser168Ter) | not provided [RCV000994969] | uncertain significance | 12 | 109101964 | 109101965 | Human | | name |
| 28868076 | CV869171 | single nucleotide variant | NM_080911.3(UNG):c.664C>G (p.Gln222Glu) | Hyper-IgM syndrome type 5 [RCV001112234] | uncertain significance | 12 | 109103474 | 109103474 | Human | 1 | name |
| 28868079 | CV869172 | single nucleotide variant | NM_080911.3(UNG):c.812A>G (p.His271Arg) | Hyper-IgM syndrome type 5 [RCV001112235] | uncertain significance | 12 | 109109839 | 109109839 | Human | 1 | name |
| 38477758 | CV926453 | single nucleotide variant | NM_080911.3(UNG):c.318C>A (p.Phe106Leu) | Hyper-IgM syndrome type 5 [RCV001216290] | uncertain significance | 12 | 109098617 | 109098617 | Human | 1 | name |
| 38479631 | CV926454 | single nucleotide variant | NM_080911.3(UNG):c.638A>G (p.Asn213Ser) | Hyper-IgM syndrome type 5 [RCV001217087] | uncertain significance | 12 | 109103448 | 109103448 | Human | 1 | name |
| 38487157 | CV926455 | single nucleotide variant | NM_080911.3(UNG):c.839C>T (p.Pro280Leu) | Hyper-IgM syndrome type 5 [RCV001220635] | uncertain significance | 12 | 109109866 | 109109866 | Human | 1 | name |
| 38481871 | CV947771 | single nucleotide variant | NM_080911.3(UNG):c.415C>A (p.Gln139Lys) | Hyper-IgM syndrome type 5 [RCV001235322] | uncertain significance | 12 | 109099264 | 109099264 | Human | 1 | name |
| 38483730 | CV947772 | single nucleotide variant | NM_080911.3(UNG):c.631C>A (p.Leu211Ile) | Hyper-IgM syndrome type 5 [RCV001236044] | uncertain significance | 12 | 109103441 | 109103441 | Human | 1 | name |
| 38456213 | CV947773 | single nucleotide variant | NM_080911.3(UNG):c.653T>G (p.Val218Gly) | Hyper-IgM syndrome type 5 [RCV001228277] | uncertain significance | 12 | 109103463 | 109103463 | Human | 1 | name |
| 38486913 | CV947774 | single nucleotide variant | NM_080911.3(UNG):c.824C>T (p.Thr275Met) | Hyper-IgM syndrome type 5 [RCV001237357] | uncertain significance | 12 | 109109851 | 109109851 | Human | 1 | name |
| 38498500 | CV956739 | single nucleotide variant | NM_080911.3(UNG):c.868T>G (p.Cys290Gly) | Hyper-IgM syndrome type 5 [RCV001243867] | uncertain significance | 12 | 109109895 | 109109895 | Human | 1 | name |
| 126734576 | CV994877 | single nucleotide variant | NM_080911.3(UNG):c.452T>C (p.Leu151Pro) | Hyper-IgM syndrome type 5 [RCV001294940] | uncertain significance | 12 | 109101918 | 109101918 | Human | 1 | name |
| 126752561 | CV994878 | single nucleotide variant | NM_080911.3(UNG):c.487C>G (p.His163Asp) | Hyper-IgM syndrome type 5 [RCV001297755]|not specified [RCV004036082] | uncertain significance | 12 | 109101953 | 109101953 | Human | 1 | name |
| 126761728 | CV994879 | single nucleotide variant | NM_080911.3(UNG):c.508C>G (p.Gln170Glu) | Hyper-IgM syndrome type 5 [RCV001300180] | uncertain significance | 12 | 109101974 | 109101974 | Human | 1 | name |
| 126762372 | CV994880 | single nucleotide variant | NM_080911.3(UNG):c.620A>G (p.Gln207Arg) | Hyper-IgM syndrome type 5 [RCV001300374] | uncertain significance | 12 | 109102925 | 109102925 | Human | 1 | name |
| 150450059 | CV1254063 | insertion | NM_080911.3(UNG):c.802-48_802-47insAAAAT | not provided [RCV001667700] | benign | 12 | 109109781 | 109109782 | Human | | name |
| 150545442 | CV1315590 | deletion | NM_080911.3(UNG):c.569_570del (p.Ile190fs) | Hyper-IgM syndrome type 5 [RCV003513623] | pathogenic|likely pathogenic | 12 | 109102873 | 109102874 | Human | 1 | name |
| 151839656 | CV1364271 | microsatellite | NM_080911.3(UNG):c.366_369del (p.Arg122fs) | Hyper-IgM syndrome type 5 [RCV001994580] | pathogenic | 12 | 109099208 | 109099211 | Human | | name |
| 151794905 | CV1420627 | microsatellite | NM_080911.3(UNG):c.778AAG[1] (p.Lys261del) | Hyper-IgM syndrome type 5 [RCV002027562] | uncertain significance | 12 | 109103586 | 109103588 | Human | | name |
| 8563030 | CV27330 | microsatellite | NM_080911.3(UNG):c.572_573del (p.Glu191fs) | Hyper-IgM syndrome type 5 [RCV000013085] | pathogenic | 12 | 109102875 | 109102876 | Human | | name |
| 8563031 | CV27332 | deletion | NM_080911.3(UNG):c.428_429del (p.Ile143fs) | Hyper-IgM syndrome type 5 [RCV000013087] | pathogenic | 12 | 109099276 | 109099277 | Human | 1 | name |
| 597670061 | CV3707110 | deletion | NM_080911.3(UNG):c.551_552del (p.Lys184fs) | Hyper-IgM syndrome type 5 [RCV005004786] | likely pathogenic | 12 | 109102855 | 109102856 | Human | 1 | name |
| 151829737 | CV1465901 | deletion | NM_080911.3(UNG):c.47_73del (p.Ala16_Pro24del) | Hyper-IgM syndrome type 5 [RCV002050605] | uncertain significance | 12 | 109097714 | 109097740 | Human | 1 | name |
| 126908917 | CV1052897 | deletion | NM_080911.3(UNG):c.294del (p.Ser97_Trp98insTer) | Hyper-IgM syndrome type 5 [RCV001374665] | pathogenic | 12 | 109098592 | 109098592 | Human | 1 | name |
| 26901103 | CV839253 | indel | NM_080911.3(UNG):c.178_182delinsCAGGAGGA (p.Thr60_Pro61delinsGlnGluGlu) | Hyper-IgM syndrome type 5 [RCV001055860] | uncertain significance | 12 | 109098477 | 109098481 | Human | | name |
| 9589507 | CV165961 | single nucleotide variant | NM_015278.5(SASH1):c.1849G>A (p.Glu617Lys) | Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma [RCV000766196]|Palmoplantar keratoderma [RCV000144361] | pathogenic|likely pathogenic | 6 | 148533885 | 148533885 | Human | 4 | alternate_id |
| 126765874 | CV1025142 | single nucleotide variant | NM_003722.5(TP63):c.1121C>T (p.Thr374Met) | ADULT syndrome [RCV002486385]|TP63-Related Spectrum Disorders [RCV001342203] | uncertain significance | 3 | 189868708 | 189868708 | Human | 9 | alternate_id |
| 126773774 | CV1025143 | single nucleotide variant | NM_003722.5(TP63):c.1697C>T (p.Thr566Met) | ADULT syndrome [RCV002493783]|ADULT syndrome [RCV005394964]|TP63-Related Spectrum Disorders [RCV001346460] | uncertain significance | 3 | 189890833 | 189890833 | Human | 10 | alternate_id |
| 126919893 | CV1042089 | single nucleotide variant | NM_003722.5(TP63):c.799G>A (p.Val267Ile) | ADULT syndrome [RCV003333764]|TP63-Related Spectrum Disorders [RCV001362555] | uncertain significance | 3 | 189866714 | 189866714 | Human | 1 | alternate_id |
| 127271285 | CV1059703 | single nucleotide variant | NM_003722.5(TP63):c.1670G>T (p.Gly557Val) | ADULT syndrome [RCV003136064]|TP63-Related Spectrum Disorders [RCV001390109] | pathogenic|likely pathogenic | 3 | 189890806 | 189890806 | Human | 1 | alternate_id |
| 127250186 | CV1092295 | single nucleotide variant | NM_003722.5(TP63):c.1626G>A (p.Pro542=) | ADULT syndrome [RCV002488244]|TP63-Related Spectrum Disorders [RCV001436269]|TP63-related disorder [RCV003938759] | likely benign | 3 | 189889458 | 189889458 | Human | 9 | alternate_id |
| 150550837 | CV1305253 | single nucleotide variant | NM_003722.5(TP63):c.2021G>A (p.Arg674His) | ADULT syndrome [RCV002488602]|not provided [RCV001766033]|not specified [RCV003331198] | uncertain significance | 3 | 189894480 | 189894480 | Human | 1 | alternate_id |
| 151348570 | CV1324098 | single nucleotide variant | NM_003722.5(TP63):c.802G>A (p.Glu268Lys) | ADULT syndrome [RCV003154197]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV001808011] | likely pathogenic|uncertain significance | 3 | 189866717 | 189866717 | Human | 2 | alternate_id |
| 151853375 | CV1349257 | single nucleotide variant | NM_003722.5(TP63):c.1814G>A (p.Arg605Gln) | ADULT syndrome [RCV002484467]|TP63-Related Spectrum Disorders [RCV001923091]|not provided [RCV002272528] | benign|uncertain significance | 3 | 189894273 | 189894273 | Human | 9 | alternate_id |
| 151814983 | CV1349905 | single nucleotide variant | NM_003722.5(TP63):c.1612A>G (p.Thr538Ala) | ADULT syndrome [RCV002486578]|TP63-Related Spectrum Disorders [RCV002012813] | uncertain significance | 3 | 189889444 | 189889444 | Human | 9 | alternate_id |
| 151885063 | CV1364252 | single nucleotide variant | NM_003722.5(TP63):c.1095G>A (p.Ser365=) | ADULT syndrome [RCV002497866]|TP63-Related Spectrum Disorders [RCV002037680] | likely benign | 3 | 189868682 | 189868682 | Human | 9 | alternate_id |
| 151874204 | CV1369448 | single nucleotide variant | NM_003722.5(TP63):c.1394C>T (p.Pro465Leu) | ADULT syndrome [RCV002479821]|TP63-Related Spectrum Disorders [RCV002036054] | uncertain significance | 3 | 189886438 | 189886438 | Human | 9 | alternate_id |
| 151744388 | CV1404678 | single nucleotide variant | NM_003722.5(TP63):c.1352C>G (p.Thr451Ser) | ADULT syndrome [RCV002479739]|TP63-Related Spectrum Disorders [RCV002022652] | likely benign|uncertain significance | 3 | 189886396 | 189886396 | Human | 9 | alternate_id |
| 151793304 | CV1423061 | single nucleotide variant | NM_003722.5(TP63):c.50C>G (p.Pro17Arg) | ADULT syndrome [RCV002479438]|TP63-Related Spectrum Disorders [RCV001917025] | uncertain significance | 3 | 189631565 | 189631565 | Human | 9 | alternate_id |
| 151841883 | CV1423847 | single nucleotide variant | NM_003722.5(TP63):c.2003G>A (p.Arg668His) | ADULT syndrome [RCV002507738]|TP63-Related Spectrum Disorders [RCV001977796] | likely benign|uncertain significance | 3 | 189894462 | 189894462 | Human | 9 | alternate_id |
| 151799806 | CV1430725 | microsatellite | NM_003722.5(TP63):c.1831TCC[1] (p.Ser612del) | ADULT syndrome [RCV002482573]|TP63-Related Spectrum Disorders [RCV001877272] | uncertain significance | 3 | 189894289 | 189894291 | Human | | alternate_id |
| 151774305 | CV1430865 | single nucleotide variant | NM_003722.5(TP63):c.1537G>C (p.Ala513Pro) | ADULT syndrome [RCV005023331]|TP63-Related Spectrum Disorders [RCV001864370] | benign|uncertain significance | 3 | 189889369 | 189889369 | Human | 10 | alternate_id |
| 151849384 | CV1431343 | single nucleotide variant | NM_003722.5(TP63):c.110G>A (p.Arg37Gln) | ADULT syndrome [RCV002482760]|TP63-Related Spectrum Disorders [RCV001922562] | uncertain significance | 3 | 189737787 | 189737787 | Human | 9 | alternate_id |
| 151777826 | CV1436728 | single nucleotide variant | NM_003722.5(TP63):c.1570G>A (p.Ala524Thr) | ADULT syndrome [RCV002466729]|TP63-Related Spectrum Disorders [RCV001971798] | uncertain significance | 3 | 189889402 | 189889402 | Human | 1 | alternate_id |
| 151800604 | CV1442183 | single nucleotide variant | NM_003722.5(TP63):c.62G>A (p.Arg21His) | ADULT syndrome [RCV002479771]|TP63-Related Spectrum Disorders [RCV002011531]|not provided [RCV004697185] | uncertain significance | 3 | 189631577 | 189631577 | Human | 9 | alternate_id |
| 151667729 | CV1460838 | single nucleotide variant | NM_003722.5(TP63):c.1583C>A (p.Pro528Gln) | ADULT syndrome [RCV005038437]|TP63-Related Spectrum Disorders [RCV001888941]|not provided [RCV002508326] | uncertain significance | 3 | 189889415 | 189889415 | Human | 10 | alternate_id |
| 151856688 | CV1470088 | microsatellite | NM_003722.5(TP63):c.1507+6_1507+7del | ADULT syndrome [RCV005023350]|TP63-Related Spectrum Disorders [RCV001883415] | uncertain significance | 3 | 189886555 | 189886556 | Human | | alternate_id |
| 151878707 | CV1493932 | single nucleotide variant | NM_003722.5(TP63):c.1807G>C (p.Asp603His) | ADULT syndrome [RCV005002692]|TP63-Related Spectrum Disorders [RCV001982230]|TP63-related disorder [RCV004746523] | likely benign|uncertain significance | 3 | 189894266 | 189894266 | Human | 10 | alternate_id |
| 151810559 | CV1497405 | single nucleotide variant | NM_003722.5(TP63):c.882+19A>T | ADULT syndrome [RCV002503666]|TP63-Related Spectrum Disorders [RCV001974726] | likely benign | 3 | 189866816 | 189866816 | Human | 9 | alternate_id |
| 152058632 | CV1531940 | single nucleotide variant | NM_003722.5(TP63):c.498C>T (p.Pro166=) | ADULT syndrome [RCV002494016]|TP63-Related Spectrum Disorders [RCV002089997] | benign|likely benign | 3 | 189808445 | 189808445 | Human | 9 | alternate_id |
| 152049809 | CV1540384 | single nucleotide variant | NM_003722.5(TP63):c.654A>G (p.Pro218=) | ADULT syndrome [RCV002494367]|TP63-Related Spectrum Disorders [RCV002108809] | likely benign | 3 | 189864306 | 189864306 | Human | 9 | alternate_id |
| 152030112 | CV1570681 | single nucleotide variant | NM_003722.5(TP63):c.156A>G (p.Pro52=) | ADULT syndrome [RCV002500006]|TP63-Related Spectrum Disorders [RCV002105821]|TP63-related disorder [RCV004747045] | likely benign | 3 | 189737833 | 189737833 | Human | 9 | alternate_id |
| 152034565 | CV1610617 | single nucleotide variant | NM_003722.5(TP63):c.20G>T (p.Arg7Leu) | ADULT syndrome [RCV002480958]|TP63-Related Spectrum Disorders [RCV002125117]|TP63-related disorder [RCV003913742] | benign|likely benign | 3 | 189631535 | 189631535 | Human | 9 | alternate_id |
| 152156613 | CV1630419 | single nucleotide variant | NM_003722.5(TP63):c.1367C>T (p.Pro456Leu) | ADULT syndrome [RCV005025708]|TP63-Related Spectrum Disorders [RCV002122523]|not provided [RCV002464516] | benign|uncertain significance | 3 | 189886411 | 189886411 | Human | 10 | alternate_id |
| 152082144 | CV1641473 | single nucleotide variant | NM_003722.5(TP63):c.475C>T (p.Leu159Phe) | ADULT syndrome [RCV005025689]|TP63-Related Spectrum Disorders [RCV002211558] | likely benign | 3 | 189808422 | 189808422 | Human | 10 | alternate_id |
| 152103002 | CV1656672 | single nucleotide variant | NM_003722.5(TP63):c.1575C>T (p.Leu525=) | ADULT syndrome [RCV002507993]|TP63-Related Spectrum Disorders [RCV002115592] | likely benign | 3 | 189889407 | 189889407 | Human | 9 | alternate_id |
| 152091800 | CV1662273 | single nucleotide variant | NM_003722.5(TP63):c.1480A>G (p.Thr494Ala) | ADULT syndrome [RCV005025709]|TP63-Related Spectrum Disorders [RCV002132136] | benign|uncertain significance | 3 | 189886524 | 189886524 | Human | 10 | alternate_id |
| 156243495 | CV1893882 | single nucleotide variant | NM_003722.5(TP63):c.1861A>G (p.Ser621Gly) | ADULT syndrome [RCV005028202]|TP63-Related Spectrum Disorders [RCV003085834] | uncertain significance | 3 | 189894320 | 189894320 | Human | 10 | alternate_id |
| 155935080 | CV1916343 | single nucleotide variant | NM_003722.5(TP63):c.1518G>A (p.Met506Ile) | ADULT syndrome [RCV005034735]|TP63-Related Spectrum Disorders [RCV002615244] | uncertain significance | 3 | 189889350 | 189889350 | Human | 10 | alternate_id |
| 10048503 | CV193526 | deletion | NM_003722.5(TP63):c.192-9_192-8del | ADULT syndrome [RCV002503681]|TP63-Related Spectrum Disorders [RCV001080338]|not provided [RCV000514456]|not specified [RCV000177177] | benign|likely benign | 3 | 189738632 | 189738633 | Human | 9 | alternate_id |
| 156445331 | CV1945338 | single nucleotide variant | NM_003722.5(TP63):c.2040G>C (p.Glu680Asp) | ADULT syndrome [RCV005029906]|TP63-Related Spectrum Disorders [RCV003116272] | uncertain significance | 3 | 189894499 | 189894499 | Human | 10 | alternate_id |
| 156404778 | CV1993507 | single nucleotide variant | NM_003722.5(TP63):c.1594C>G (p.Pro532Ala) | ADULT syndrome [RCV005025921]|TP63-Related Spectrum Disorders [RCV002658136] | uncertain significance | 3 | 189889426 | 189889426 | Human | 10 | alternate_id |
| 10408567 | CV204361 | deletion | NM_003722.5(TP63):c.1963del (p.Arg655fs) | ADULT syndrome [RCV000195096] | pathogenic | 3 | 189894419 | 189894419 | Human | | alternate_id |
| 156103729 | CV2096311 | single nucleotide variant | NM_003722.5(TP63):c.1481C>T (p.Thr494Ile) | ADULT syndrome [RCV005028014]|TP63-Related Spectrum Disorders [RCV002913503] | uncertain significance | 3 | 189886525 | 189886525 | Human | 10 | alternate_id |
| 8559391 | CV21566 | single nucleotide variant | NM_003722.5(TP63):c.727C>T (p.Arg243Trp) | ADULT syndrome [RCV005025017]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000006900]|Rapp-Hodgkin syndrome [RCV002283440]|TP63-Related Spectrum Disorders [RCV000812084]|not provided [RCV000394306] | pathogenic | 3 | 189864379 | 189864379 | Human | 10 | alternate_id |
| 8559398 | CV21573 | single nucleotide variant | NM_003722.5(TP63):c.1028G>A (p.Arg343Gln) | ADULT syndrome [RCV005025018]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000006908]|Inborn genetic diseases [RCV001266717]|TP63-Related Spectrum Disorders [RCV000655484]|not provided [RCV000276670] | pathogenic|likely pathogenic | 3 | 189868615 | 189868615 | Human | 11 | alternate_id |
| 8559401 | CV21576 | single nucleotide variant | NM_001114980.2(TP63):c.16A>C (p.Asn6His) | ADULT syndrome [RCV000006911] | pathogenic | 3 | 189789816 | 189789816 | Human | 1 | alternate_id |
| 8559404 | CV21579 | single nucleotide variant | NM_003722.5(TP63):c.1010G>A (p.Arg337Gln) | ADULT syndrome [RCV000006914]|TP63-Related Spectrum Disorders [RCV000794231]|not provided [RCV001781195] | pathogenic|likely pathogenic | 3 | 189868597 | 189868597 | Human | 1 | alternate_id |
| 8559410 | CV21585 | single nucleotide variant | TP63, VAL114MET | ADULT syndrome [RCV000006921] | pathogenic | | | | Human | 1 | alternate_id |
| 8559412 | CV21587 | single nucleotide variant | NM_003722.5(TP63):c.1009C>G (p.Arg337Gly) | ADULT syndrome [RCV000006923]|not provided [RCV001280741] | pathogenic | 3 | 189868596 | 189868596 | Human | 1 | alternate_id |
| 8559413 | CV21588 | single nucleotide variant | NM_003722.5(TP63):c.289C>T (p.Arg97Cys) | ADULT syndrome [RCV005031401]|Split hand-foot malformation 4 [RCV000006924]|TP63-Related Spectrum Disorders [RCV001851711] | pathogenic|uncertain significance | 3 | 189738739 | 189738739 | Human | 10 | alternate_id |
| 8559414 | CV21589 | single nucleotide variant | NM_003722.5(TP63):c.797G>A (p.Arg266Gln) | ADULT syndrome [RCV000006926]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000006925]|TP63-Related Spectrum Disorders [RCV001390108]|not provided [RCV000413620] | pathogenic|likely pathogenic | 3 | 189866712 | 189866712 | Human | 3 | alternate_id |
| 8559416 | CV21591 | single nucleotide variant | P127L | ADULT syndrome [RCV000006928] | pathogenic | | | | Human | 1 | alternate_id |
| 156439983 | CV2401667 | single nucleotide variant | NM_003722.5(TP63):c.19C>T (p.Arg7Trp) | ADULT syndrome [RCV005036644]|TP63-Related Spectrum Disorders [RCV003757247]|not provided [RCV003109955] | uncertain significance | 3 | 189631534 | 189631534 | Human | 10 | alternate_id |
| 11579142 | CV271227 | single nucleotide variant | NM_003722.5(TP63):c.1531C>A (p.Pro511Thr) | ADULT syndrome [RCV002480032]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000296599]|Orofacial cleft 8 [RCV000399267]|TP63-Related Spectrum Disorders [RCV000351504]|not provided [RCV001572958]|not specified [RCV000384210] | benign|likely benign | 3 | 189889363 | 189889363 | Human | 9 | alternate_id |
| 401937844 | CV2797181 | single nucleotide variant | NM_003722.5(TP63):c.122C>T (p.Ser41Phe) | ADULT syndrome [RCV005036783]|TP63-Related Spectrum Disorders [RCV005062890]|TP63-related disorder [RCV003416940]|not provided [RCV005228029] | uncertain significance | 3 | 189737799 | 189737799 | Human | 10 | alternate_id |
| 405051637 | CV2887732 | single nucleotide variant | NM_003722.5(TP63):c.1661C>T (p.Ala554Val) | ADULT syndrome [RCV005030092]|TP63-Related Spectrum Disorders [RCV003592908] | likely benign|uncertain significance | 3 | 189890797 | 189890797 | Human | 10 | alternate_id |
| 11585921 | CV294095 | single nucleotide variant | NM_003722.5(TP63):c.992+4A>C | ADULT syndrome [RCV002502321]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000283959]|Orofacial cleft 8 [RCV000321352]|TP63-Related Spectrum Disorders [RCV000378424]|not provided [RCV001618612] | benign|likely benign | 3 | 189867946 | 189867946 | Human | 9 | alternate_id |
| 405167746 | CV3031152 | single nucleotide variant | NM_003722.5(TP63):c.362A>G (p.Asp121Gly) | ADULT syndrome [RCV005030203]|TP63-Related Spectrum Disorders [RCV003757890] | pathogenic|uncertain significance | 3 | 189808309 | 189808309 | Human | 10 | alternate_id |
| 405154965 | CV3054728 | single nucleotide variant | NM_003722.5(TP63):c.1223G>A (p.Arg408His) | ADULT syndrome [RCV005030227]|TP63-Related Spectrum Disorders [RCV003756675] | uncertain significance | 3 | 189872869 | 189872869 | Human | 10 | alternate_id |
| 405160213 | CV3076485 | single nucleotide variant | NM_003722.5(TP63):c.1898C>G (p.Thr633Ser) | ADULT syndrome [RCV005392690]|Inborn genetic diseases [RCV004968444]|TP63-Related Spectrum Disorders [RCV003757122] | uncertain significance | 3 | 189894357 | 189894357 | Human | 9 | alternate_id |
| 405199905 | CV3128867 | single nucleotide variant | NM_003722.5(TP63):c.1142A>G (p.Asn381Ser) | ADULT syndrome [RCV005038545]|TP63-Related Spectrum Disorders [RCV003821910] | uncertain significance | 3 | 189869336 | 189869336 | Human | 10 | alternate_id |
| 597716283 | CV3717395 | single nucleotide variant | NM_003722.5(TP63):c.131C>A (p.Thr44Lys) | ADULT syndrome [RCV005035284] | uncertain significance | 3 | 189737808 | 189737808 | Human | 1 | alternate_id |
| 597637849 | CV3717396 | single nucleotide variant | NM_003722.5(TP63):c.161T>C (p.Val54Ala) | ADULT syndrome [RCV005024551] | uncertain significance | 3 | 189737838 | 189737838 | Human | 1 | alternate_id |
| 597716303 | CV3717397 | single nucleotide variant | NM_003722.5(TP63):c.325-18411A>G | ADULT syndrome [RCV005035286] | uncertain significance | 3 | 189789861 | 189789861 | Human | 1 | alternate_id |
| 597637856 | CV3717398 | duplication | NM_003722.5(TP63):c.345dup (p.Leu116fs) | ADULT syndrome [RCV005024552] | likely pathogenic | 3 | 189808288 | 189808289 | Human | 1 | alternate_id |
| 597637862 | CV3717400 | single nucleotide variant | NM_003722.5(TP63):c.543C>G (p.Phe181Leu) | ADULT syndrome [RCV005024553] | uncertain significance | 3 | 189808490 | 189808490 | Human | 1 | alternate_id |
| 597637868 | CV3717401 | single nucleotide variant | NM_003722.5(TP63):c.609C>T (p.Cys203=) | ADULT syndrome [RCV005024554] | uncertain significance | 3 | 189864261 | 189864261 | Human | 1 | alternate_id |
| 597637875 | CV3717402 | single nucleotide variant | NM_003722.5(TP63):c.809A>G (p.Asn270Ser) | ADULT syndrome [RCV005024555] | uncertain significance | 3 | 189866724 | 189866724 | Human | 1 | alternate_id |
| 597637880 | CV3717403 | single nucleotide variant | NM_003722.5(TP63):c.1129+1G>A | ADULT syndrome [RCV005024556] | likely pathogenic | 3 | 189868717 | 189868717 | Human | 1 | alternate_id |
| 597716315 | CV3717404 | single nucleotide variant | NM_003722.5(TP63):c.1160T>A (p.Met387Lys) | ADULT syndrome [RCV005035287] | uncertain significance | 3 | 189869354 | 189869354 | Human | 1 | alternate_id |
| 597716323 | CV3717405 | single nucleotide variant | NM_003722.5(TP63):c.1350-6263G>A | ADULT syndrome [RCV005035288] | uncertain significance | 3 | 189880131 | 189880131 | Human | 1 | alternate_id |
| 597637887 | CV3717406 | single nucleotide variant | NM_003722.5(TP63):c.1350-7T>A | ADULT syndrome [RCV005024557] | uncertain significance | 3 | 189886387 | 189886387 | Human | 1 | alternate_id |
| 597716335 | CV3717407 | single nucleotide variant | NM_003722.5(TP63):c.1362G>T (p.Gln454His) | ADULT syndrome [RCV005035289] | uncertain significance | 3 | 189886406 | 189886406 | Human | 1 | alternate_id |
| 597637893 | CV3717408 | single nucleotide variant | NM_003722.5(TP63):c.1525C>T (p.His509Tyr) | ADULT syndrome [RCV005024558] | uncertain significance | 3 | 189889357 | 189889357 | Human | 1 | alternate_id |
| 597716360 | CV3717409 | single nucleotide variant | NM_003722.5(TP63):c.1528A>G (p.Met510Val) | ADULT syndrome [RCV005035291] | uncertain significance | 3 | 189889360 | 189889360 | Human | 1 | alternate_id |
| 597637899 | CV3717410 | single nucleotide variant | NM_003722.5(TP63):c.1534A>G (p.Met512Val) | ADULT syndrome [RCV005024559] | uncertain significance | 3 | 189889366 | 189889366 | Human | 1 | alternate_id |
| 597716369 | CV3717411 | single nucleotide variant | NM_003722.5(TP63):c.1565C>T (p.Thr522Ile) | ADULT syndrome [RCV005035292] | uncertain significance | 3 | 189889397 | 189889397 | Human | 1 | alternate_id |
| 597637910 | CV3717412 | single nucleotide variant | NM_003722.5(TP63):c.1615C>T (p.Pro539Ser) | ADULT syndrome [RCV005024561] | uncertain significance | 3 | 189889447 | 189889447 | Human | 1 | alternate_id |
| 597716381 | CV3717413 | single nucleotide variant | NM_003722.5(TP63):c.1797G>A (p.Lys599=) | ADULT syndrome [RCV005035293] | uncertain significance | 3 | 189894256 | 189894256 | Human | 1 | alternate_id |
| 597637916 | CV3717414 | single nucleotide variant | NM_003722.5(TP63):c.1835C>A (p.Ser612Tyr) | ADULT syndrome [RCV005024562] | uncertain significance | 3 | 189894294 | 189894294 | Human | 1 | alternate_id |
| 597637922 | CV3717415 | single nucleotide variant | NM_003722.5(TP63):c.1847T>G (p.Leu616Arg) | ADULT syndrome [RCV005024563] | uncertain significance | 3 | 189894306 | 189894306 | Human | 1 | alternate_id |
| 597637928 | CV3717416 | single nucleotide variant | NM_003722.5(TP63):c.2009A>G (p.Asn670Ser) | ADULT syndrome [RCV005024564] | uncertain significance | 3 | 189894468 | 189894468 | Human | 1 | alternate_id |
| 597637933 | CV3717417 | single nucleotide variant | NM_003722.5(TP63):c.2036G>A (p.Gly679Glu) | ADULT syndrome [RCV005024565] | uncertain significance | 3 | 189894495 | 189894495 | Human | 1 | alternate_id |
| 598188445 | CV4008583 | microsatellite | NM_001329964.2(TP63):c.22_23del (p.Asp8fs) | ADULT syndrome [RCV005396082] | uncertain significance | 3 | 189597199 | 189597200 | Human | | alternate_id |
| 13836449 | CV587723 | single nucleotide variant | NM_003722.5(TP63):c.290G>A (p.Arg97His) | ADULT syndrome [RCV005004394]|TP63-Related Spectrum Disorders [RCV001855687]|TP63-related disorder [RCV004745572]|not provided [RCV000732570] | uncertain significance | 3 | 189738740 | 189738740 | Human | 10 | alternate_id |
| 15139714 | CV691358 | single nucleotide variant | NM_003722.5(TP63):c.402T>C (p.Tyr134=) | ADULT syndrome [RCV002478994]|TP63-Related Spectrum Disorders [RCV002064880] | likely benign | 3 | 189808349 | 189808349 | Human | 9 | alternate_id |
| 15139742 | CV691359 | single nucleotide variant | NM_003722.5(TP63):c.714G>A (p.Thr238=) | ADULT syndrome [RCV002507540]|TP63-Related Spectrum Disorders [RCV005056655] | likely benign | 3 | 189864366 | 189864366 | Human | 9 | alternate_id |
| 15142189 | CV691360 | single nucleotide variant | NM_003722.5(TP63):c.1788G>A (p.Ala596=) | ADULT syndrome [RCV002495327]|TP63-Related Spectrum Disorders [RCV002064892]|TP63-related disorder [RCV003967945] | benign|likely benign | 3 | 189894247 | 189894247 | Human | 9 | alternate_id |
| 15153493 | CV697987 | single nucleotide variant | NM_003722.5(TP63):c.1599C>T (p.Ser533=) | ADULT syndrome [RCV002505406]|TP63-Related Spectrum Disorders [RCV001479077]|TP63-related disorder [RCV003925862]|not provided [RCV000946092] | likely benign | 3 | 189889431 | 189889431 | Human | 9 | alternate_id |
| 15109403 | CV708731 | single nucleotide variant | NM_003722.5(TP63):c.366G>A (p.Gln122=) | ADULT syndrome [RCV002505442]|TP63-Related Spectrum Disorders [RCV002066373]|not provided [RCV000960693] | benign|likely benign | 3 | 189808313 | 189808313 | Human | 9 | alternate_id |
| 15145057 | CV733957 | single nucleotide variant | NM_003722.5(TP63):c.84T>G (p.His28Gln) | ADULT syndrome [RCV005029527]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV001144653]|Orofacial cleft 8 [RCV001144652]|TP63-Related Spectrum Disorders [RCV001144654] | benign|likely benign|uncertain significance | 3 | 189737761 | 189737761 | Human | 10 | alternate_id |
| 15113394 | CV787261 | single nucleotide variant | NM_003722.5(TP63):c.992+8G>A | ADULT syndrome [RCV002505488]|TP63-Related Spectrum Disorders [RCV002066467] | likely benign | 3 | 189867950 | 189867950 | Human | 9 | alternate_id |
| 21071281 | CV790373 | single nucleotide variant | NM_003722.5(TP63):c.1528A>T (p.Met510Leu) | ADULT syndrome [RCV005029546]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000987374]|TP63-Related Spectrum Disorders [RCV001858664] | uncertain significance | 3 | 189889360 | 189889360 | Human | 10 | alternate_id |
| 8625584 | CV80708 | single nucleotide variant | NM_003722.5(TP63):c.1825G>A (p.Glu609Lys) | ADULT syndrome [RCV002504980]|Split hand-foot malformation 4 [RCV001270760] | uncertain significance|not provided | 3 | 189894284 | 189894284 | Human | 2 | alternate_id |
| 28904884 | CV888501 | single nucleotide variant | NM_003722.5(TP63):c.210G>C (p.Gln70His) | ADULT syndrome [RCV005029719]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV001144655]|Orofacial cleft 8 [RCV001144656]|TP63-Related Spectrum Disorders [RCV001144657] | benign|likely benign|uncertain significance | 3 | 189738660 | 189738660 | Human | 10 | alternate_id |